{"meta":{"query_hash":"46dfdd0e24f0","filters":{"venue":"Journal of Managed Care & Specialty Pharmacy"},"cohort_total":52,"direct_labels_cover":0,"predictions_cover":52,"exported":52,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/46dfdd0e24f0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Managed+Care+%26+Specialty+Pharmacy"},"results":[{"id":"W1174528165","doi":"10.18553/jmcp.2015.21.9.s1","title":"New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; American Society of Transplantation; U.S. Department of Veterans Affairs","keywords":"Medicine; Context (archaeology); Pharmacy; Hepatitis C; Promotion (chess); Panel discussion; Population; Health care; Medical education; Family medicine; Immunology; Political science; Business","score_opus":0.066420816437532,"score_gpt":0.4022039364016684,"score_spread":0.3357831199641364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1174528165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9047781,0.06779522,0.000011203867,0.016543932,0.00044849716,0.0004885893,0.000011774929,0.000009263651,0.009913386],"genre_scores_gemma":[0.9555909,0.037142668,0.002118576,0.0014170813,0.0025417884,0.000016467367,0.000011095777,0.000033842345,0.0011275593],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971871,0.0005750149,0.0005773829,0.00031858438,0.0010765567,0.00026538386],"domain_scores_gemma":[0.99776083,0.00045142943,0.0006010464,0.00027057473,0.00044002704,0.0004760624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088725804,0.00020360238,0.00035277603,0.00029252996,0.00017903665,0.00017606883,0.00030968737,0.00004478705,0.0002354816],"category_scores_gemma":[0.00050342164,0.00014933341,0.000056024834,0.00027106522,0.000116093266,0.0011987292,0.00022455497,0.00049593387,0.000010015657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024177951,0.00027260042,0.6678588,0.00021663205,0.00049221434,0.0016439657,0.09456975,0.000024414154,0.0023501567,0.0003125106,0.098371126,0.13147002],"study_design_scores_gemma":[0.0061830967,0.00044535383,0.43738562,0.0012277677,0.00022051563,0.00015019932,0.0171237,0.00013104841,0.00086096907,0.00069157,0.5352526,0.0003275901],"about_ca_topic_score_codex":0.0052765957,"about_ca_topic_score_gemma":0.006715089,"teacher_disagreement_score":0.43688145,"about_ca_system_score_codex":0.000474881,"about_ca_system_score_gemma":0.0004376785,"threshold_uncertainty_score":0.79766697},"labels":[],"label_agreement":null},{"id":"W2202332854","doi":"10.18553/jmcp.2015.21.11.982","title":"Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Administration (probate law); Immunotherapy; MEDLINE; Food and drug administration; Clinical Practice; Dermatology; Intensive care medicine; Family medicine; Immunology; Pharmacology; Immune system","score_opus":0.04688621297761729,"score_gpt":0.37005682723714584,"score_spread":0.32317061425952853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202332854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821949,0.0041255215,0.0001014757,0.006578781,0.0004742924,0.00044329127,0.000014838006,0.0000038442113,0.006063064],"genre_scores_gemma":[0.9887918,0.0075308285,0.0020073613,0.0006430624,0.0009304128,0.00000143731,0.000014244769,0.000016722332,0.00006412131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861044,0.00013810115,0.0007216881,0.00012403003,0.00026321074,0.0001425114],"domain_scores_gemma":[0.99828106,0.00022016605,0.00043247527,0.0000825701,0.0006808107,0.0003028951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087677396,0.000104143255,0.0003817098,0.00019380495,0.00004170132,0.000031354833,0.000054568984,0.000061785926,0.000024939272],"category_scores_gemma":[0.0005531509,0.00009672749,0.000072426534,0.00009230466,0.000059720034,0.00016943413,0.0000097436905,0.00025284447,5.8126926e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038649593,0.00063275005,0.025538918,0.000636156,0.0012917641,0.020235945,0.04886106,0.0002379166,0.0012147938,0.0018707162,0.022404244,0.8384262],"study_design_scores_gemma":[0.036753315,0.0064281574,0.036221683,0.00049725967,0.0005361405,0.015450374,0.035106223,0.0015008877,0.0003479396,0.0007423882,0.8659294,0.00048620292],"about_ca_topic_score_codex":0.0032296844,"about_ca_topic_score_gemma":0.009244429,"teacher_disagreement_score":0.8435252,"about_ca_system_score_codex":0.00013016089,"about_ca_system_score_gemma":0.00070511777,"threshold_uncertainty_score":0.5158608},"labels":[],"label_agreement":null},{"id":"W2281295224","doi":"10.18553/jmcp.2016.22.4.381","title":"Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"Providence Health Care; University of Washington; Washington State University","keywords":"Medicine; Emergency department; Medical prescription; Medical emergency; Health care; Emergency medicine; Family medicine; Medical record; Nursing","score_opus":0.03557528796684232,"score_gpt":0.3324076329152418,"score_spread":0.29683234494839944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281295224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923951,0.0004413686,0.0018248691,0.0017515245,0.0012569521,0.0007744959,0.0000030838823,0.000018056964,0.0015345686],"genre_scores_gemma":[0.9976777,0.0005447019,0.00036440257,0.00035024527,0.0007399406,0.000020842677,0.000005885266,0.000013849056,0.00028246772],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873024,0.00007001622,0.0003799979,0.00017944904,0.00047581593,0.00016446733],"domain_scores_gemma":[0.9988556,0.00003357524,0.00034240374,0.00012570551,0.00040506,0.00023763729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017173134,0.0001227805,0.00020520469,0.00010389629,0.0000826076,0.000019009922,0.00009072517,0.000023012555,0.00019583774],"category_scores_gemma":[0.00024307474,0.000084543244,0.000068990965,0.0001505264,0.000012118249,0.00014844004,0.000023887924,0.000121802936,0.000057091314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048787773,0.00026690098,0.14026102,0.00020113109,0.000060651055,0.00003248057,0.00057465927,6.325027e-7,0.0011083487,0.00006627862,0.009740102,0.8471999],"study_design_scores_gemma":[0.008370408,0.0031798559,0.72241694,0.0020669631,0.00025357812,0.00001562634,0.0006652806,0.000015723723,0.010004492,0.00013030955,0.25259268,0.00028812647],"about_ca_topic_score_codex":0.0000019118183,"about_ca_topic_score_gemma":0.0000051623633,"teacher_disagreement_score":0.8469118,"about_ca_system_score_codex":0.00017947277,"about_ca_system_score_gemma":0.000038166563,"threshold_uncertainty_score":0.34475735},"labels":[],"label_agreement":null},{"id":"W2342848062","doi":"10.18553/jmcp.2016.22.5.539","title":"Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Reimbursement; Medicine; Deductible; Medical prescription; Quartile; Retrospective cohort study; Cohort; Family medicine; Emergency medicine; Health care; Internal medicine; Actuarial science; Nursing; Confidence interval","score_opus":0.03015981882170532,"score_gpt":0.33390441544237304,"score_spread":0.3037445966206677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342848062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976175,0.00051289605,0.00004414822,0.00031199635,0.0004003668,0.0004628724,0.00009310471,0.0000045533925,0.0005526056],"genre_scores_gemma":[0.9984206,0.0010754737,0.000098368844,0.00025717524,0.000076018034,0.000010201078,0.000011712037,0.000012703263,0.00003773575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976731,0.00012837346,0.0009667632,0.00019705357,0.0008441653,0.00019055909],"domain_scores_gemma":[0.99779356,0.000118671334,0.0013239058,0.00022974201,0.00034301376,0.00019108571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019798016,0.00017355086,0.00044583355,0.000189376,0.000032483662,0.000006961376,0.00016980423,0.00003236163,0.00035827202],"category_scores_gemma":[0.00022507849,0.00011543506,0.000111403526,0.00013634877,0.00008811541,0.00014818506,0.0000417366,0.0002087502,0.0000103146895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028523926,0.0009143041,0.6066601,0.00020504765,0.00015242917,0.000026089281,0.0050938153,0.0000116363035,0.008693444,0.00001788375,0.020877782,0.35449505],"study_design_scores_gemma":[0.013334892,0.0036247778,0.922784,0.0039820014,0.00010026053,0.0000070303404,0.0012797028,0.000010409846,0.04687504,0.00007983183,0.0076613836,0.00026068315],"about_ca_topic_score_codex":0.000035239187,"about_ca_topic_score_gemma":0.0000054293528,"teacher_disagreement_score":0.35423434,"about_ca_system_score_codex":0.00025309363,"about_ca_system_score_gemma":0.00014463018,"threshold_uncertainty_score":0.4707305},"labels":[],"label_agreement":null},{"id":"W2401364644","doi":"10.18553/jmcp.2016.22.6.676","title":"Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Université de Montréal; Sanofi","keywords":"Warfarin; Prospective cohort study; Medicine; MEDLINE; Cohort study; Internal medicine; Atrial fibrillation; Political science","score_opus":0.062329631686486316,"score_gpt":0.3387078272128758,"score_spread":0.2763781955263895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401364644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449253,0.00045667603,0.000220354,0.0018958722,0.00019282436,0.0004808769,0.0000053034114,0.000007030101,0.0022485342],"genre_scores_gemma":[0.9969285,0.0011976185,0.00049467204,0.00029970286,0.00033363205,0.0000045238135,7.259852e-7,0.000010772819,0.00072986464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985043,0.00008639124,0.00059567404,0.0001849382,0.00046160302,0.00016712549],"domain_scores_gemma":[0.99861985,0.000115266106,0.0004120973,0.00021111149,0.00039041904,0.0002512281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046786448,0.00012357543,0.00042995502,0.00016652915,0.000024826695,0.000014454159,0.00013921138,0.000032227133,0.0008646816],"category_scores_gemma":[0.0004870328,0.000083513,0.00009013601,0.00023803425,0.00011476236,0.00029384633,0.000044869696,0.000286059,0.000015198971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084093923,0.00010685763,0.96295726,0.0001007125,0.00007621119,0.00007300951,0.0011385079,4.835988e-7,0.004188547,0.00008781218,0.0036049352,0.026824731],"study_design_scores_gemma":[0.005863444,0.00018861207,0.9669475,0.00042614245,0.00011483791,0.00004929399,0.0008484652,0.0000034726097,0.008083897,0.00026135895,0.017119274,0.00009370998],"about_ca_topic_score_codex":0.00016609493,"about_ca_topic_score_gemma":0.0001028658,"teacher_disagreement_score":0.026731022,"about_ca_system_score_codex":0.00025521114,"about_ca_system_score_gemma":0.0003783153,"threshold_uncertainty_score":0.9467657},"labels":[],"label_agreement":null},{"id":"W2417977696","doi":"10.18553/jmcp.2015.21.12.1116","title":"Proceedings of the AMCP Partnership Forum: Breaking the Link Between Pain Management and Opioid Use Disorder","year":2015,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Substance Abuse Prevention; Center for Substance Abuse Treatment; Substance Abuse and Mental Health Services Administration; Depomed; Office of National Drug Control Policy; York University; Purdue Pharma; Zogenix; Medical Center, University of Pittsburgh; University of Pittsburgh; Purdue University; Kaiser Permanente; U.S. Food and Drug Administration; CVS Health; Blue Cross Blue Shield of Massachusetts","keywords":"Opioid use disorder; Opioid; Pain management; General partnership; Chronic pain; Medicine; Psychiatry; Psychology; Psychotherapist; Political science; Physical therapy; Internal medicine","score_opus":0.041338335328335966,"score_gpt":0.31370339447129736,"score_spread":0.2723650591429614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417977696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718551,0.0031894252,0.000054433887,0.017251242,0.0003538751,0.0012999553,0.000010028427,0.000021062491,0.0059648715],"genre_scores_gemma":[0.9959362,0.0007304536,0.00048329716,0.0007822278,0.0014681958,0.000014292029,0.0000040537834,0.000042223885,0.00053901545],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977963,0.00012671357,0.00064642425,0.00021289338,0.0008864213,0.0003312739],"domain_scores_gemma":[0.9982502,0.00015406526,0.0006362005,0.00024280044,0.00048826885,0.0002284611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103107,0.0002583746,0.0004694528,0.00016669715,0.00016488788,0.000106874235,0.00038824783,0.0000464982,0.000019790828],"category_scores_gemma":[0.00019285595,0.00014549776,0.00026353146,0.0003715998,0.00013490104,0.0002543333,0.00023387029,0.0005042746,0.0000028401496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045609134,0.00011652865,0.79716223,0.000565788,0.00077422167,0.000058168527,0.0094565675,0.000013423762,0.000036789348,0.00059030537,0.01583069,0.1749392],"study_design_scores_gemma":[0.008440278,0.00042262286,0.41287777,0.0006806707,0.0022383165,0.00006856865,0.033742696,0.000038018115,0.00068799464,0.00079463876,0.53975683,0.00025160113],"about_ca_topic_score_codex":0.00007815769,"about_ca_topic_score_gemma":0.000033038996,"teacher_disagreement_score":0.52392614,"about_ca_system_score_codex":0.00022156409,"about_ca_system_score_gemma":0.00011281469,"threshold_uncertainty_score":0.59332263},"labels":[],"label_agreement":null},{"id":"W2511824391","doi":"10.18553/jmcp.2016.22.9.1064","title":"Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"Amgen","keywords":"Ivabradine; Medicine; Heart failure; Medicare Advantage; Formulary; Emergency medicine; Internal medicine; Cardiology; Heart rate; Health care; Pharmacology; Blood pressure","score_opus":0.009468308968254735,"score_gpt":0.30812053404780193,"score_spread":0.2986522250795472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511824391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965732,0.0010823263,0.000029440762,0.0012942307,0.00008166395,0.0007259619,0.00010475963,0.0000043604414,0.00010405928],"genre_scores_gemma":[0.99882764,0.00043519895,0.00011928915,0.00021980125,0.00033910823,0.0000042246197,0.000023686182,0.00002672668,0.0000043251994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743134,0.00039800978,0.00073936424,0.00015781072,0.0009213156,0.00035213825],"domain_scores_gemma":[0.99831975,0.000106414,0.00030093567,0.00030718234,0.00076159224,0.00020413041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008664665,0.0001930137,0.0008716065,0.00075514364,0.000038298425,0.000012486111,0.00019775017,0.000041287447,0.00008460332],"category_scores_gemma":[0.00009547822,0.00010034831,0.00032630019,0.00096091384,0.000050095063,0.00013603803,0.000032219545,0.0003977685,0.0000023352045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011995104,0.00032909706,0.91813654,0.0022281623,0.0008105329,0.0004167121,0.017735861,0.0022182525,0.0013297002,0.000022841557,0.009837324,0.03493989],"study_design_scores_gemma":[0.025337424,0.0077555613,0.8649101,0.004019005,0.00037458344,0.00009310115,0.0073675932,0.0000065316303,0.002157978,0.0000061312103,0.08771578,0.00025617925],"about_ca_topic_score_codex":0.0005941047,"about_ca_topic_score_gemma":0.0012100367,"teacher_disagreement_score":0.07787846,"about_ca_system_score_codex":0.0012715406,"about_ca_system_score_gemma":0.00077536405,"threshold_uncertainty_score":0.40920854},"labels":[],"label_agreement":null},{"id":"W2524035794","doi":"10.18553/jmcp.2016.22.10.1204","title":"Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Dutasteride; Finasteride; Medicine; Benign prostatic hyperplasia (BPH); 5 Alpha-Reductase Inhibitor; Urology; Hyperplasia; Erectile dysfunction; Internal medicine; Prostate","score_opus":0.06852659501174793,"score_gpt":0.37090273950568703,"score_spread":0.3023761444939391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524035794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838984,0.00007999521,0.000006776781,0.00083282223,0.000017447763,0.00052749465,0.000015259244,0.000002552366,0.00012782207],"genre_scores_gemma":[0.9986405,0.001126891,0.00008110134,0.00007149216,0.000029469149,0.000005004025,0.00001431913,0.000014241921,0.000016983127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830043,0.0004958235,0.0006434593,0.00012487592,0.00028621027,0.00014921279],"domain_scores_gemma":[0.9986692,0.0005432046,0.00043289436,0.0000971102,0.0001864261,0.000071131966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011972927,0.000121391866,0.0004799521,0.0003504618,0.00003054478,0.00002734971,0.00009374642,0.000025767507,0.00001753867],"category_scores_gemma":[0.000066860746,0.000059500886,0.000028635248,0.00018359974,0.00015606082,0.00028166454,0.00002295967,0.00024477922,1.8010962e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009519499,0.0003067729,0.9771693,0.0000757803,0.00015661918,0.0001825798,0.005861934,0.00001842477,0.0002127551,0.000012831521,0.000018215234,0.006465291],"study_design_scores_gemma":[0.020886326,0.0033889068,0.97050935,0.00037656768,0.000065431865,0.00008309484,0.003513856,0.00034535845,0.0006183081,0.00005063489,0.00008554147,0.000076605655],"about_ca_topic_score_codex":0.00021315213,"about_ca_topic_score_gemma":0.00073139893,"teacher_disagreement_score":0.011366828,"about_ca_system_score_codex":0.00006836414,"about_ca_system_score_gemma":0.00013827998,"threshold_uncertainty_score":0.24263757},"labels":[],"label_agreement":null},{"id":"W2559773245","doi":"10.18553/jmcp.2016.16233","title":"Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech; Astellas Pharma; Janssen Scientific Affairs; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; GlaxoSmithKline; Pfizer; Allergan; Bristol-Myers Squibb","keywords":"Abiraterone acetate; Enzalutamide; Medicine; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Oncology; Docetaxel; Cancer; Urology; Gynecology; Androgen deprivation therapy; Confidence interval","score_opus":0.030423283707478124,"score_gpt":0.34325781161561675,"score_spread":0.31283452790813865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559773245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964159,0.0009422848,0.0000031559769,0.0010143811,0.00013052924,0.0009448289,0.00006507203,0.000009052442,0.0004747803],"genre_scores_gemma":[0.9878292,0.009232875,0.000072599054,0.000046706875,0.00024596287,0.00004327221,0.000014902117,0.00003153852,0.0024829514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982659,0.00011608499,0.00063829566,0.00019626075,0.0004743518,0.0003090971],"domain_scores_gemma":[0.99853593,0.000052950883,0.00049010804,0.00014371703,0.0006024947,0.00017479435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015349197,0.0002208334,0.00052742125,0.0002993415,0.0000465538,0.000017547227,0.00009648762,0.000027659753,0.000299214],"category_scores_gemma":[0.000027261638,0.00009992637,0.000107626285,0.00034318,0.00009059803,0.00025763313,0.0000204185,0.00014159385,0.0000058409364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035510447,0.00074683054,0.7800178,0.00024996808,0.0005930245,0.0010685746,0.0025158352,0.000025581066,0.022388786,0.0000029168457,0.00041125732,0.15646899],"study_design_scores_gemma":[0.10078572,0.01000951,0.5502481,0.002001527,0.00088150235,0.00007179326,0.00092257047,0.000012245463,0.31900072,0.000016299713,0.015708588,0.00034144204],"about_ca_topic_score_codex":0.00029413815,"about_ca_topic_score_gemma":0.00075918675,"teacher_disagreement_score":0.29661193,"about_ca_system_score_codex":0.0016930929,"about_ca_system_score_gemma":0.0006012924,"threshold_uncertainty_score":0.4427379},"labels":[],"label_agreement":null},{"id":"W2580021056","doi":"10.18553/jmcp.2017.23.2.214","title":"Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Myeloid leukemia; Emergency medicine; Health care; Internal medicine; Incidence (geometry); Intensive care medicine","score_opus":0.015540074172635065,"score_gpt":0.29812006386282514,"score_spread":0.28257998969019005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580021056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922601,0.0057825646,0.000018517228,0.0004957094,0.00013645981,0.0009651676,0.000016873893,0.00001315942,0.0003114481],"genre_scores_gemma":[0.9974913,0.00042637874,0.0011430314,0.00028373947,0.0005516615,0.000012952419,0.000027081584,0.00005347557,0.000010381687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979321,0.00011925151,0.0005030512,0.00038060898,0.000678413,0.00038660198],"domain_scores_gemma":[0.9980801,0.000030533352,0.00064595614,0.00040926266,0.0003556983,0.000478487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020050921,0.00032033076,0.00057120615,0.00030427426,0.0002824303,0.00012339292,0.00019243931,0.00005424128,0.00001272621],"category_scores_gemma":[0.00008470159,0.00025441084,0.00004771599,0.00018753165,0.00010960681,0.00032659326,0.00010598735,0.00050954847,0.0000014618348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001617108,0.000064664564,0.8027114,0.00037671128,0.0000985774,0.000648396,0.0016028694,0.00002052002,0.00052824296,0.0000030865226,0.0001346529,0.19219373],"study_design_scores_gemma":[0.026702212,0.002775777,0.9584089,0.0032722019,0.00024142054,0.00006446695,0.00074733567,0.000008359331,0.005956022,0.0000025330567,0.0015330435,0.000287725],"about_ca_topic_score_codex":0.0016640745,"about_ca_topic_score_gemma":0.00094229745,"teacher_disagreement_score":0.191906,"about_ca_system_score_codex":0.0059755044,"about_ca_system_score_gemma":0.001010855,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W2580331578","doi":"10.18553/jmcp.2017.23.2.125","title":"Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Family medicine; Medicine; MEDLINE; Agency (philosophy); Health care; Political science","score_opus":0.05962344223072856,"score_gpt":0.362654184564635,"score_spread":0.3030307423339064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580331578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92519826,0.010479301,0.00022698496,0.0028756761,0.0030160954,0.0004012621,0.00008782322,0.000012751674,0.05770187],"genre_scores_gemma":[0.99389684,0.003164751,0.00094713207,0.0010275819,0.00082557206,0.0000063527627,0.0000021757264,0.00003868968,0.000090877744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99718827,0.000056516703,0.0017526975,0.00042051962,0.00012551092,0.00045647236],"domain_scores_gemma":[0.9950306,0.00015650305,0.0038675633,0.0005511262,0.00020556703,0.0001886498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007886518,0.0002724957,0.0011348154,0.00061887415,0.0003960509,0.00022105423,0.00066656026,0.000094765346,0.00037883164],"category_scores_gemma":[0.0008898891,0.00027282911,0.00036791724,0.00009157982,0.00010520575,0.0006013074,0.00013165192,0.00061621977,0.00006260865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014115418,0.000411482,0.46110848,0.00010010775,0.00026061368,0.00045860413,0.03536326,0.0004126469,0.0000039709084,0.019549532,0.0056768833,0.47524288],"study_design_scores_gemma":[0.0044727,0.00063594163,0.54077554,0.00017678496,0.000017744309,0.000021624655,0.01258313,0.000013049561,0.000022978911,0.0039431076,0.43697506,0.00036235902],"about_ca_topic_score_codex":0.00056102715,"about_ca_topic_score_gemma":0.0010192519,"teacher_disagreement_score":0.47488052,"about_ca_system_score_codex":0.0021274982,"about_ca_system_score_gemma":0.00028927508,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W2582881778","doi":"10.18553/jmcp.2017.23.2.247","title":"Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Family medicine; Prescription drug; Anticancer drug; Drug approval; Orphan drug; Medical prescription; Drug; Health care; Pharmacology; Political science","score_opus":0.05968202333567807,"score_gpt":0.31493782344998567,"score_spread":0.2552558001143076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582881778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830195,0.0036697357,0.0002106843,0.0026715992,0.00030383488,0.00017322428,0.000039542567,0.000002145964,0.009909784],"genre_scores_gemma":[0.9902242,0.008307983,0.000078187026,0.00088982855,0.00040647745,0.0000015099893,0.0000016313327,0.000011783667,0.00007839492],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989455,0.00004748856,0.00064022513,0.00012930442,0.00005450551,0.00018302402],"domain_scores_gemma":[0.99817324,0.00029687435,0.0011588294,0.00021161207,0.000090284935,0.000069173235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010333117,0.00011882752,0.00046403514,0.00019875338,0.00027567768,0.00021879347,0.00048443,0.000040295647,0.000051840216],"category_scores_gemma":[0.00028529234,0.00008638578,0.00006257302,0.00011260442,0.00020490409,0.00028193498,0.0000875353,0.00035082438,0.0000036190625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024004,0.000106876025,0.85785306,0.00006930412,0.0002622971,0.000035117177,0.0452872,0.00063553633,0.000011023295,0.04720835,0.014489703,0.033039153],"study_design_scores_gemma":[0.0032639075,0.000101927275,0.41255772,0.00004495433,0.00003649019,0.000025083833,0.0026399929,0.00039288768,0.000031502732,0.00884127,0.5719299,0.00013440751],"about_ca_topic_score_codex":0.0024650556,"about_ca_topic_score_gemma":0.0012501443,"teacher_disagreement_score":0.55744016,"about_ca_system_score_codex":0.00011152173,"about_ca_system_score_gemma":0.00010253181,"threshold_uncertainty_score":0.3726443},"labels":[],"label_agreement":null},{"id":"W2589158462","doi":"10.18553/jmcp.2017.23.3.355","title":"Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Medical prescription; Medicine; Prescription drug; Quarter (Canadian coin); Family medicine; Medicare Part D; Health care; Emergency medicine; Nursing; Economic growth; Economics","score_opus":0.06662123829369185,"score_gpt":0.3341867324161187,"score_spread":0.2675654941224268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589158462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97516805,0.0052940473,0.00077514205,0.006482267,0.0019929993,0.0004428598,0.00002479074,0.000011732461,0.009808109],"genre_scores_gemma":[0.9905087,0.008106011,0.00020473634,0.0005164324,0.00041868107,0.00000678901,0.000006061288,0.00001795654,0.00021464305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983645,0.00008544561,0.0009066997,0.00023665949,0.00014402204,0.00026266725],"domain_scores_gemma":[0.9983953,0.000029353743,0.0010577366,0.00028726723,0.000058434918,0.00017190636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018894691,0.000142432,0.00039057236,0.00043018867,0.0002714275,0.00017816677,0.00032102654,0.000031709074,0.000097995646],"category_scores_gemma":[0.00023807805,0.00015566118,0.00011827007,0.00007162581,0.0000360145,0.0006567534,0.00012811035,0.000277733,0.00002151933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008770766,0.0005039763,0.3976641,0.0012904549,0.0004918672,0.00087365933,0.021164177,0.00028604275,0.00026890184,0.031986155,0.04455759,0.500036],"study_design_scores_gemma":[0.006425072,0.00010562923,0.379787,0.00032147014,0.00005861853,0.0000072963644,0.0013302693,0.00082400156,0.00036904588,0.009562748,0.60083604,0.00037281337],"about_ca_topic_score_codex":0.005224559,"about_ca_topic_score_gemma":0.0017540031,"teacher_disagreement_score":0.55627847,"about_ca_system_score_codex":0.00028174097,"about_ca_system_score_gemma":0.0000474845,"threshold_uncertainty_score":0.7898005},"labels":[],"label_agreement":null},{"id":"W2589462389","doi":"10.18553/jmcp.2017.23.3.337","title":"Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of North Carolina at Chapel Hill; Gillings School of Public Health; AcademyHealth; Robert Wood Johnson Foundation","keywords":"Medicaid; Medical prescription; Copayment; Medicine; Baseline (sea); Population; Quarter (Canadian coin); Prescription drug; Medication adherence; Family medicine; Demography; Health insurance; Environmental health; Internal medicine; Health care; Nursing","score_opus":0.041861920922275156,"score_gpt":0.3965196124528042,"score_spread":0.35465769153052906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589462389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93393385,0.0040848316,0.00047656626,0.025672069,0.002551129,0.0011240623,0.00007032034,0.000044069973,0.032043114],"genre_scores_gemma":[0.989317,0.0049737236,0.000109029876,0.0010772247,0.002858616,0.000025500041,0.000020504409,0.000021520003,0.0015969094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675375,0.00034254283,0.00078536815,0.000296066,0.0015075953,0.00031466465],"domain_scores_gemma":[0.9958852,0.00037434677,0.002044958,0.0006945738,0.0005212679,0.00047966157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015672263,0.00028893823,0.0008312537,0.0002996673,0.0002536207,0.00005336179,0.001003582,0.00009345373,0.0020081317],"category_scores_gemma":[0.0024577063,0.00020644121,0.00021265457,0.00019600305,0.0003660122,0.00014702072,0.000084583786,0.00069504156,0.00011634442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019264151,0.0002787908,0.024797762,0.00093523075,0.00023195577,0.000113959926,0.0007021364,6.76351e-7,0.008711277,0.00017190089,0.07431973,0.8878102],"study_design_scores_gemma":[0.04552944,0.026675956,0.19345076,0.011614789,0.002578396,0.00042121488,0.0027685713,0.00047156966,0.29679957,0.0005921594,0.41766053,0.0014370207],"about_ca_topic_score_codex":0.00017967411,"about_ca_topic_score_gemma":0.000031677104,"teacher_disagreement_score":0.88637316,"about_ca_system_score_codex":0.00014865732,"about_ca_system_score_gemma":0.00047731824,"threshold_uncertainty_score":0.99890417},"labels":[],"label_agreement":null},{"id":"W2609767893","doi":"10.18553/jmcp.2017.23.5.566","title":"Exploring Electronic Medical Record and Self-Administered Medication Risk Screening Tools in a Primary Care Clinic","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Grey Nuns Community Hospital; University of Alberta","funders":"","keywords":"Medicine; Pharmacist; Health literacy; Health care; MEDLINE; Medical record; Family medicine; Electronic medical record; Pharmacy; Internal medicine","score_opus":0.19407124811116977,"score_gpt":0.46429965834549614,"score_spread":0.27022841023432637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609767893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726426,0.00605862,0.0003188413,0.0029717132,0.0036393248,0.0014048187,0.000015060802,0.000062219966,0.0128867775],"genre_scores_gemma":[0.950416,0.042264342,0.0007941594,0.00072139525,0.005465624,0.00012016795,0.000013499121,0.00007133484,0.00013346813],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.992181,0.0023725885,0.0024838601,0.00045890844,0.0012667947,0.0012368269],"domain_scores_gemma":[0.9933408,0.0012617394,0.0035619924,0.00065850397,0.00047864125,0.00069834484],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007195886,0.0003239018,0.0009968971,0.00043944293,0.0015960198,0.00009241053,0.0010526002,0.00023618514,0.00033444542],"category_scores_gemma":[0.0020860536,0.0003015536,0.00019836397,0.00018252025,0.000087770335,0.0010808661,0.00033057632,0.004866574,0.00004962604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007606922,0.00008294661,0.33396065,0.0020958201,0.00014707094,0.00023595833,0.014226059,6.786862e-7,0.000018306502,0.000050227332,0.0011517453,0.64726985],"study_design_scores_gemma":[0.013063431,0.0006669178,0.5483773,0.0038547034,0.00026938773,0.00008213091,0.017491605,0.0000970423,0.00002720056,0.0001010194,0.41548604,0.0004832626],"about_ca_topic_score_codex":0.00086513115,"about_ca_topic_score_gemma":0.0056555457,"teacher_disagreement_score":0.6467866,"about_ca_system_score_codex":0.0027642027,"about_ca_system_score_gemma":0.004525565,"threshold_uncertainty_score":0.9999437},"labels":[],"label_agreement":null},{"id":"W2617020364","doi":"10.18553/jmcp.2017.23.6.633","title":"The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"PTC Therapeutics; Sarepta Therapeutics; GlaxoSmithKline; Eli Lilly and Company","keywords":"Medicine; Duchenne muscular dystrophy; Diagnosis code; Cohort; Pharmacy; Health care; Cohort study; Medical prescription; Emergency medicine; Pediatrics; Family medicine; Internal medicine; Population; Environmental health","score_opus":0.014379722324745903,"score_gpt":0.315511823919588,"score_spread":0.3011321015948421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617020364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302644,0.003335828,0.00006172868,0.0024076991,0.00016390742,0.00023233792,0.00001837256,0.000002970272,0.0007507181],"genre_scores_gemma":[0.99360526,0.005539719,0.000013165864,0.0004621102,0.0002821789,0.000007742083,0.00006056955,0.000016559303,0.000012713222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831736,0.0005032299,0.00033797554,0.0001846234,0.00040268866,0.0002540997],"domain_scores_gemma":[0.99856967,0.00015426178,0.0005838012,0.0003107737,0.00024171754,0.00013980705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092512375,0.00017087457,0.0002441525,0.0000800466,0.00053043937,0.00014637246,0.00067178975,0.00003900315,0.000013904114],"category_scores_gemma":[0.00062355615,0.000101635385,0.00011354631,0.00011520967,0.00038334526,0.000030049629,0.00013958255,0.00038895395,2.1511148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023107463,0.0020743674,0.48145092,0.0011399413,0.005643318,0.0071038255,0.005429138,0.004883684,0.031418126,0.0005392612,0.017319849,0.4198901],"study_design_scores_gemma":[0.025693074,0.00056029484,0.78946364,0.0012122688,0.001133669,0.00013057987,0.011860683,0.0025019664,0.004397933,0.00045066775,0.16166446,0.00093076006],"about_ca_topic_score_codex":0.00015546179,"about_ca_topic_score_gemma":0.00034470594,"teacher_disagreement_score":0.41895935,"about_ca_system_score_codex":0.00003724555,"about_ca_system_score_gemma":0.00015958726,"threshold_uncertainty_score":0.41445708},"labels":[],"label_agreement":null},{"id":"W2619351549","doi":"10.18553/jmcp.2017.23.6-a.s34","title":"Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting","year":2017,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"David Geffen School of Medicine, University of California, Los Angeles; California State University, East Bay; Eisai; Memorial Sloan-Kettering Cancer Center; University of California, Los Angeles; City of Hope; Tufts Medical Center","keywords":"Medicine; Concordance; Oncology; Clinical Oncology; Intraclass correlation; Prostate cancer; Breast cancer; Internal medicine; Inter-rater reliability; Cancer; Family medicine; Gynecology; Statistics; Psychometrics; Clinical psychology","score_opus":0.27371123389672003,"score_gpt":0.4738505961901953,"score_spread":0.2001393622934753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619351549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92931175,0.0013650692,0.0012301038,0.05751973,0.001251889,0.0006417708,0.00003863223,0.0000037175403,0.008637333],"genre_scores_gemma":[0.99241084,0.00077065075,0.0033987456,0.0021092677,0.0012634388,0.0000070639417,0.0000011489249,0.000015935044,0.000022907898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935571,0.0015885378,0.003995129,0.0002773229,0.00029926523,0.0002826775],"domain_scores_gemma":[0.98846614,0.0025795407,0.007870832,0.0007458441,0.00021736213,0.000120303564],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.045685124,0.00017076242,0.0010835673,0.00021114653,0.00038548498,0.00012212351,0.0011079849,0.00013308747,0.00007230864],"category_scores_gemma":[0.006184963,0.00014009638,0.0002479259,0.0001117072,0.00019534794,0.00046926903,0.00017493022,0.0011945534,0.0000057748935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024647257,0.00043637308,0.83560544,0.0017624232,0.00025715504,0.000020830252,0.07561203,0.006450333,0.000021933378,0.044737443,0.016717635,0.018131938],"study_design_scores_gemma":[0.003250679,0.00019833639,0.87537736,0.00040711564,0.00010258052,0.00002187129,0.020388374,0.002346613,0.00007117828,0.03659445,0.060975816,0.0002656435],"about_ca_topic_score_codex":0.0019022743,"about_ca_topic_score_gemma":0.00018367186,"teacher_disagreement_score":0.06309909,"about_ca_system_score_codex":0.000733349,"about_ca_system_score_gemma":0.00055072334,"threshold_uncertainty_score":0.982668},"labels":[],"label_agreement":null},{"id":"W2690274894","doi":"10.18553/jmcp.2017.23.6-b.s2","title":"The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis","year":2017,"lang":"en","type":"review","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"Genentech; H. Lundbeck A/S; Acorda Therapeutics; Allergan; ACADIA Pharmaceuticals; Eisai; Sunovion; Teva Pharmaceutical Industries","keywords":"Psychosis; Parkinson's disease; Disease; Disease management; Medicine; MEDLINE; Psychiatry; Pathology; Political science","score_opus":0.061933536909485734,"score_gpt":0.3984877224697301,"score_spread":0.33655418556024436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2690274894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009337205,0.99145645,0.0000054840225,0.000264988,0.0006773411,0.0013271525,0.00008840746,0.000005021417,0.0052414075],"genre_scores_gemma":[0.028520834,0.9703832,0.00013652603,0.000049082446,0.0006064221,0.000069588255,0.000018271541,0.000054228192,0.00016181906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636865,0.0004220477,0.0014340596,0.00030692935,0.0011045858,0.00036370385],"domain_scores_gemma":[0.9959402,0.00012034564,0.002521656,0.00096662994,0.00020343564,0.00024771446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010996351,0.00046073573,0.0016966701,0.0003702886,0.00022713844,0.00006610217,0.0012042766,0.000059224043,0.00008349573],"category_scores_gemma":[0.000039734667,0.0002537521,0.001511625,0.0002938125,0.00010070784,0.000108384906,0.000144968,0.00062305346,0.000008769247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005318955,0.00043073663,0.0005142159,0.011586852,0.0018828193,0.001359903,0.000318325,0.0000016399126,6.25373e-7,0.00019743055,0.00091248495,0.9822631],"study_design_scores_gemma":[0.0023048038,0.00009278615,0.006390988,0.013214029,0.008646178,0.000042756907,0.0010182261,0.000002605868,0.000004687662,0.00016149651,0.9679455,0.00017594888],"about_ca_topic_score_codex":0.000038000868,"about_ca_topic_score_gemma":0.000030090327,"teacher_disagreement_score":0.98208714,"about_ca_system_score_codex":0.00027383695,"about_ca_system_score_gemma":0.000264044,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W2785395993","doi":"10.18553/jmcp.2018.24.2.173","title":"Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"","keywords":"Medicine; Kidney disease; Pharmacy; Internal medicine; Randomized controlled trial; Medication therapy management; Nephrology; Pharmaceutical care; Cluster (spacecraft); Physical therapy; Pharmacist; Emergency medicine; Family medicine","score_opus":0.05018344472814139,"score_gpt":0.37036973219362135,"score_spread":0.32018628746547995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785395993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999155,0.0028897382,0.000021253505,0.0006265045,0.00038525066,0.0049663684,0.0000640004,0.000006054181,0.0010492835],"genre_scores_gemma":[0.9911698,0.008069549,0.000064303356,0.00031923104,0.00011796033,0.00005212243,0.000018151053,0.000019159655,0.00016972898],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940354,0.002476384,0.0021695667,0.00020097628,0.0008238641,0.00029379793],"domain_scores_gemma":[0.99639374,0.0008049026,0.0017350332,0.0002461089,0.00046070834,0.00035949008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003772001,0.0002765657,0.0019511242,0.0004902512,0.00007590618,0.000022108328,0.0002998117,0.000043932338,0.00033042536],"category_scores_gemma":[0.00075738906,0.0002082299,0.00054619764,0.0005065056,0.00036865662,0.00035215422,0.0001746289,0.0008387216,0.0000015002634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86387545,0.0019222605,0.121178485,0.005198965,0.0016346348,0.0000383689,0.0030601318,0.000045488858,0.000109929024,0.000010321495,0.00078226987,0.0021436992],"study_design_scores_gemma":[0.97212136,0.00041046037,0.017860753,0.0013894498,0.00436445,0.0000027078918,0.00035128064,0.0020697438,0.00022974928,0.00006623727,0.0009487363,0.00018505646],"about_ca_topic_score_codex":0.00016716744,"about_ca_topic_score_gemma":0.0000627199,"teacher_disagreement_score":0.10824593,"about_ca_system_score_codex":0.00030584645,"about_ca_system_score_gemma":0.00020971411,"threshold_uncertainty_score":0.8491369},"labels":[],"label_agreement":null},{"id":"W2800541776","doi":"10.18553/jmcp.2018.24.5.464","title":"Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Toronto General Hospital; St. Michael's Hospital","funders":"Leslie Dan Faculty of Pharmacy, University of Toronto; Department of Medicine, University of Toronto; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Research Institute","keywords":"Medicine; Reimbursement; Public health; Family medicine; Hepatitis B; Hepatitis B virus; Christian ministry; Health care; Environmental health; Virology; Nursing; Economic growth; Political science","score_opus":0.06051758302697124,"score_gpt":0.35822636008654873,"score_spread":0.2977087770595775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800541776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943352,0.00027982687,0.000009224338,0.00027285647,0.0011449687,0.00091546914,0.000016328093,0.000027856766,0.0029983195],"genre_scores_gemma":[0.9954944,0.0006039046,0.00010026391,0.00050231337,0.0026340485,0.000024647676,0.000012687532,0.000040702296,0.00058699085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733853,0.00031216117,0.0008248249,0.000358244,0.00065588235,0.00051034905],"domain_scores_gemma":[0.99852556,0.000052320116,0.0004080236,0.0003546187,0.00037222204,0.00028728103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005019375,0.00031444727,0.0008279834,0.00045965333,0.00013228742,0.000106199404,0.00027109575,0.000058274894,0.004757493],"category_scores_gemma":[0.00006657522,0.0002617315,0.00022666961,0.00027359452,0.00008766017,0.00045256718,0.00011844841,0.0005708887,0.000070779046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043629456,0.0013296737,0.94230336,0.000025484702,0.0004164818,0.0025839326,0.009133821,0.000002853775,0.000036831483,0.000006208568,0.0018944846,0.04183055],"study_design_scores_gemma":[0.010383273,0.007509098,0.91847914,0.000081661354,0.0003772476,0.00006377197,0.0012905347,0.000008915998,0.00015014455,0.000022962287,0.061422575,0.00021069846],"about_ca_topic_score_codex":0.41980535,"about_ca_topic_score_gemma":0.9925226,"teacher_disagreement_score":0.57271725,"about_ca_system_score_codex":0.008171708,"about_ca_system_score_gemma":0.00068087765,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W2883086901","doi":"10.18553/jmcp.2018.18058","title":"Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Migraine; Medical prescription; Population; Observational study; Emergency department; Diagnosis code; Prescription drug; Pediatrics; Emergency medicine; Psychiatry; Internal medicine","score_opus":0.06578407431193879,"score_gpt":0.3887354786487766,"score_spread":0.32295140433683783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883086901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90970504,0.036166392,0.0010889639,0.021390343,0.0005797134,0.0030897018,0.00046626825,0.00007514517,0.027438445],"genre_scores_gemma":[0.9825865,0.0086204875,0.001572379,0.00085268065,0.0044934284,0.000049637543,0.000049803406,0.00004576669,0.0017292966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842995,0.000079558915,0.0005716899,0.00030325842,0.0002720667,0.00034347366],"domain_scores_gemma":[0.9980911,0.0002247243,0.00037440466,0.00023917422,0.0006934514,0.00037712572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023907017,0.00026483185,0.0005504752,0.00015395538,0.0003363154,0.000049948743,0.00011862096,0.0000347502,0.000095983465],"category_scores_gemma":[0.000257808,0.00021479985,0.0003792371,0.00019245897,0.00016086388,0.00022818164,0.00006910301,0.00022806329,0.000007601372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008153318,0.0016891664,0.06159284,0.0006364995,0.009173849,0.0004241177,0.016174996,0.0000038579306,0.006349522,0.00222717,0.7995551,0.09401954],"study_design_scores_gemma":[0.016342446,0.0016240643,0.26021278,0.00074911426,0.0065899147,0.00027911036,0.0052830144,0.000021094376,0.0023026816,0.00084920024,0.7052103,0.0005362438],"about_ca_topic_score_codex":0.00003123404,"about_ca_topic_score_gemma":0.00012237484,"teacher_disagreement_score":0.19861995,"about_ca_system_score_codex":0.00046248027,"about_ca_system_score_gemma":0.00012907364,"threshold_uncertainty_score":0.87592834},"labels":[],"label_agreement":null},{"id":"W2885976838","doi":"10.18553/jmcp.2018.24.8.759","title":"Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia","year":2018,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Medicine; Medicaid; Schizophrenia (object-oriented programming); Antipsychotic; Discontinuation; Paliperidone; Population; Randomized controlled trial; Inclusion and exclusion criteria; Internal medicine; Psychiatry; Environmental health; Alternative medicine","score_opus":0.018293389058894036,"score_gpt":0.31818188202287473,"score_spread":0.2998884929639807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885976838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538004,0.0017672159,0.00016800768,0.0006057333,0.0005289811,0.0008647572,0.000015887199,0.000024746902,0.00064464385],"genre_scores_gemma":[0.9950853,0.00031395297,0.0015710919,0.00003643767,0.0029038908,0.000012040609,0.000005969958,0.000048041937,0.00002330138],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969772,0.00039169868,0.00069216656,0.00031086704,0.0011401641,0.000487905],"domain_scores_gemma":[0.99752104,0.00035416728,0.000795333,0.00028976976,0.00071113004,0.0003285826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010417617,0.00034343422,0.0007328317,0.00036692663,0.0007402926,0.00013567365,0.00023490934,0.00006509869,0.00007240618],"category_scores_gemma":[0.00042785087,0.00020266575,0.00025303016,0.000580012,0.00056924095,0.00036235587,0.00013297712,0.0009129295,0.0000019999345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14502625,0.0005524656,0.39875072,0.0012233162,0.0052068545,0.0049204812,0.010892962,0.0010295053,0.006702774,0.00006962204,0.0003812998,0.42524374],"study_design_scores_gemma":[0.082738355,0.017558038,0.75839466,0.005687629,0.010137558,0.0048745377,0.023824908,0.0060727117,0.08739965,0.00016392181,0.0018561628,0.001291883],"about_ca_topic_score_codex":0.00080123544,"about_ca_topic_score_gemma":0.0028027273,"teacher_disagreement_score":0.42395186,"about_ca_system_score_codex":0.00029739435,"about_ca_system_score_gemma":0.00055560214,"threshold_uncertainty_score":0.8264469},"labels":[],"label_agreement":null},{"id":"W2914798425","doi":"10.18553/jmcp.2019.25.2.205","title":"Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; COPD; Exacerbation; Spirometry; Obstructive lung disease; Population; Cohort; Retrospective cohort study; Cohort study; Intensive care medicine; Emergency medicine; Rate ratio; Internal medicine; Environmental health; Asthma","score_opus":0.01654945398978596,"score_gpt":0.3188176105558088,"score_spread":0.30226815656602285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914798425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936256,0.0034167408,0.000009346561,0.00092435285,0.000100894795,0.0014793216,0.000085803666,0.000009462141,0.00034847992],"genre_scores_gemma":[0.99860644,0.00023188142,0.000060875554,0.00028158515,0.00014117657,0.0000065180334,0.0006009444,0.000030073614,0.000040476523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976005,0.00042225394,0.00060323963,0.00028087103,0.0008124502,0.00028067335],"domain_scores_gemma":[0.99865884,0.00005115536,0.0004113053,0.00018699972,0.0003654586,0.00032627195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033056928,0.0001943285,0.0004588012,0.00038260702,0.000080777834,0.00005110494,0.00011077611,0.000042143787,0.00008458377],"category_scores_gemma":[0.000073853196,0.0001792752,0.00005828399,0.0004274214,0.000045915607,0.00037351236,0.00004638427,0.00048555373,0.000002053712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005970031,0.00029245202,0.9411959,0.0009842091,0.000028968256,0.000046659832,0.0015980563,0.0001386531,0.000016616195,0.000015385453,0.00060888345,0.049104176],"study_design_scores_gemma":[0.01207388,0.00021987951,0.9823608,0.0004085397,0.000051001996,0.0000025487893,0.0021322253,0.00024607754,0.000018047425,0.000016582428,0.002322965,0.00014747014],"about_ca_topic_score_codex":0.00044997453,"about_ca_topic_score_gemma":0.00093836297,"teacher_disagreement_score":0.048956707,"about_ca_system_score_codex":0.001455051,"about_ca_system_score_gemma":0.0005422281,"threshold_uncertainty_score":0.731063},"labels":[],"label_agreement":null},{"id":"W2975189232","doi":"10.18553/jmcp.2019.25.10.1096","title":"Genome Diagnostics: Novel Strategies for Measuring Value","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"Stakeholder; Personalized medicine; Construct (python library); Comparative effectiveness research; Genetic testing; Construct validity; Test (biology); Computer science; Knowledge management; Medicine; Data science; Management science; Psychometrics; Bioinformatics; Alternative medicine; Pathology; Clinical psychology","score_opus":0.2896631934780353,"score_gpt":0.42010591160071287,"score_spread":0.13044271812267755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975189232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9098584,0.015946891,0.024948392,0.01297289,0.0075249146,0.0023661738,0.0005219929,0.000051207062,0.02580914],"genre_scores_gemma":[0.9855846,0.0009718476,0.004519221,0.0040463484,0.0044107684,0.000030401647,0.000016140822,0.00007020345,0.00035044114],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948835,0.00015461184,0.003886568,0.00037884692,0.0002267603,0.00046974522],"domain_scores_gemma":[0.99424016,0.0011315304,0.0036625909,0.00037259806,0.00035149467,0.00024159811],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009688435,0.00024962227,0.0011730824,0.0005171119,0.00018358661,0.0002482752,0.00060703524,0.00007904072,0.00057183404],"category_scores_gemma":[0.0016291366,0.0003026269,0.00041393487,0.0001687176,0.000039580096,0.0009413263,0.00006507947,0.00038129863,0.00060707727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008565499,0.00097607577,0.087788664,0.0091924975,0.002304439,0.000066086985,0.03461501,0.045334842,0.0013738816,0.76704377,0.047160286,0.0032878795],"study_design_scores_gemma":[0.008794707,0.00033241184,0.04288743,0.0003021428,0.00011266343,0.000053734115,0.01673578,0.0012630462,0.00010120335,0.020504443,0.9080248,0.0008876252],"about_ca_topic_score_codex":0.00012545756,"about_ca_topic_score_gemma":0.00005789663,"teacher_disagreement_score":0.8608645,"about_ca_system_score_codex":0.00096808653,"about_ca_system_score_gemma":0.0004143116,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W2991424058","doi":"10.18553/jmcp.2019.19174","title":"Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Medicaid; Pharmacy; Regimen; Protease inhibitor (pharmacology); Reverse-transcriptase inhibitor; Health care; Internal medicine; Pediatrics; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Family medicine","score_opus":0.012712894579016629,"score_gpt":0.29402682291888543,"score_spread":0.2813139283398688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991424058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916389,0.006012396,0.0000032725056,0.00038941667,0.00028564103,0.0007862899,0.000018236315,0.000009933432,0.0008558871],"genre_scores_gemma":[0.9953238,0.0039334423,0.000077568635,0.00025290024,0.00020574656,0.00000396113,0.00011930395,0.000031883166,0.000051402618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692875,0.00016795663,0.0009367321,0.0002691582,0.0013672371,0.00033016634],"domain_scores_gemma":[0.9983288,0.000058359557,0.00082669477,0.00019065778,0.0003498002,0.00024566962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048548327,0.00025946795,0.0007404148,0.00048357784,0.000106152176,0.00002965154,0.00018163335,0.000071555834,0.00031370283],"category_scores_gemma":[0.00004393018,0.00019603838,0.0001177908,0.00026669956,0.00007906978,0.0003123676,0.000055807668,0.00050875003,0.0000026448079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011403806,0.00040984846,0.88543695,0.00028620492,0.0001764337,0.0001408244,0.007913336,0.000006981504,0.00015203001,0.000012843046,0.00011722135,0.104206964],"study_design_scores_gemma":[0.022804525,0.0014786031,0.9717452,0.0016506613,0.00008414826,0.000025802558,0.0007973521,0.000005370886,0.0010499309,0.0000017412145,0.00018036301,0.00017633173],"about_ca_topic_score_codex":0.00022831741,"about_ca_topic_score_gemma":0.0002185286,"teacher_disagreement_score":0.10403063,"about_ca_system_score_codex":0.00086320966,"about_ca_system_score_gemma":0.00051339,"threshold_uncertainty_score":0.7994213},"labels":[],"label_agreement":null},{"id":"W3094921969","doi":"10.18553/jmcp.2020.26.11.1464","title":"ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine","year":2020,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Medicine; Migraine; Nothing; Acute migraine; Alternative medicine; MEDLINE; Traditional medicine; Family medicine; Psychiatry; Political science","score_opus":0.048225278617834814,"score_gpt":0.39853962469529136,"score_spread":0.35031434607745654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094921969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9201733,0.013503099,0.0018379649,0.045458768,0.00034270925,0.0015178865,0.00023232687,0.000040275863,0.01689366],"genre_scores_gemma":[0.9853832,0.0047253105,0.00484346,0.0020758635,0.0025146678,0.0000071436643,0.0000120836285,0.00003205309,0.0004061971],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983363,0.00005353886,0.00071280147,0.0001928719,0.00045702586,0.0002474204],"domain_scores_gemma":[0.99836516,0.00013519297,0.000506661,0.00012113774,0.00057484605,0.00029699565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003339019,0.00020542154,0.0008348846,0.00014506737,0.00009880087,0.0000178509,0.00014068418,0.000036041198,0.00012751378],"category_scores_gemma":[0.00015235657,0.00016265185,0.00042671539,0.00018432063,0.00008020305,0.0001016739,0.000083563544,0.00037977862,0.0000015636449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053933943,0.00059993326,0.059565026,0.004610492,0.00793804,0.0012998908,0.016261341,0.000023247203,0.059276808,0.0014895103,0.8206239,0.022918453],"study_design_scores_gemma":[0.014757895,0.0024638847,0.034514222,0.00031346633,0.0051511033,0.0002649242,0.00664535,0.00037606296,0.010533489,0.00012344737,0.92453045,0.00032570868],"about_ca_topic_score_codex":0.00002333375,"about_ca_topic_score_gemma":0.000043007934,"teacher_disagreement_score":0.10390658,"about_ca_system_score_codex":0.00008125617,"about_ca_system_score_gemma":0.0002227209,"threshold_uncertainty_score":0.66327494},"labels":[],"label_agreement":null},{"id":"W3136296759","doi":"10.18553/jmcp.2021.27.4.426","title":"Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Odds ratio; Pharmacy; Logistic regression; Internal medicine; Family medicine","score_opus":0.027603361707892175,"score_gpt":0.3042887938218259,"score_spread":0.2766854321139337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136296759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608666,0.0021489765,0.00001912727,0.00012686742,0.0005743308,0.00048287085,0.000042474396,0.000012213652,0.0005064652],"genre_scores_gemma":[0.9980306,0.0006915779,0.00006050462,0.00032654058,0.00071203563,0.000006352082,0.000059876966,0.000029366518,0.00008317218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977769,0.0002031947,0.00061079115,0.00023582345,0.00095456315,0.00021872151],"domain_scores_gemma":[0.99696463,0.00027362737,0.0007684078,0.00030642498,0.0014038758,0.00028302937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008211177,0.00023929655,0.0007536102,0.00019354725,0.0000729763,0.000019155144,0.00017688342,0.00002797194,0.0004936166],"category_scores_gemma":[0.00013857856,0.00017750754,0.00025992066,0.0003088045,0.00011095214,0.00020141288,0.000061917606,0.00042625333,0.000011562668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013583866,0.00088399457,0.79079705,0.0066038393,0.00090989756,0.0014182185,0.0025620123,0.0006427463,0.0109314555,0.000007255215,0.010329918,0.16132975],"study_design_scores_gemma":[0.05363957,0.0051539256,0.6642394,0.009022751,0.0030821005,0.00010873681,0.0033608607,0.00021841346,0.19454773,0.0000021578965,0.06604289,0.00058144797],"about_ca_topic_score_codex":0.000036802146,"about_ca_topic_score_gemma":0.000006271702,"teacher_disagreement_score":0.18361627,"about_ca_system_score_codex":0.00022136151,"about_ca_system_score_gemma":0.00035047563,"threshold_uncertainty_score":0.7238547},"labels":[],"label_agreement":null},{"id":"W3187389031","doi":"10.18553/jmcp.2021.21164","title":"Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Pembrolizumab; Medicine; Oncology; Clinical trial; Internal medicine; Cancer; Immunotherapy","score_opus":0.03911643639606383,"score_gpt":0.35514061684716103,"score_spread":0.3160241804510972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187389031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831733,0.011426776,0.00032953869,0.0001684909,0.00064178265,0.001029477,0.00020964693,0.000007682009,0.003013266],"genre_scores_gemma":[0.9965436,0.0015063006,0.000981936,0.00005102853,0.00058844156,0.000046495923,0.00003811412,0.000044520762,0.00019957106],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758625,0.0001885033,0.00095547445,0.00033301738,0.00059654925,0.00034020888],"domain_scores_gemma":[0.9962642,0.000663901,0.0010076204,0.00040156575,0.0014829626,0.00017971835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018135142,0.00031860566,0.0019303223,0.00054868613,0.00009354066,0.000012615587,0.0001765428,0.000055102642,0.0001700966],"category_scores_gemma":[0.00012361935,0.00027830576,0.0012622365,0.0008654591,0.00009335039,0.000081263264,0.000060651986,0.00015489108,0.0000011651626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08679977,0.006306263,0.47549123,0.008810224,0.01781972,0.012134128,0.015793273,0.012225084,0.08617877,0.000102529826,0.0013103804,0.27702862],"study_design_scores_gemma":[0.049327932,0.005692657,0.278673,0.00021176846,0.029351238,0.0006731836,0.00595573,0.00019544523,0.5983595,0.000033627304,0.03106189,0.00046400123],"about_ca_topic_score_codex":0.000066197754,"about_ca_topic_score_gemma":0.00013587989,"teacher_disagreement_score":0.51218075,"about_ca_system_score_codex":0.0012136013,"about_ca_system_score_gemma":0.00049497554,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W3215057584","doi":"10.18553/jmcp.2021.21290","title":"Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Indirect costs; Medicine; Psychiatry; Health care; Attention deficit hyperactivity disorder; Health economics; Unemployment; Population; Productivity; Economic cost; Gerontology; Depression (economics); Government (linguistics); Demography; Public health; Environmental health; Economic growth; Business; Economics; Nursing","score_opus":0.02244338430373089,"score_gpt":0.33400114181795304,"score_spread":0.31155775751422216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215057584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140227,0.0009939783,0.000102114005,0.004477238,0.0003825485,0.00043458396,0.000039531533,0.000011530507,0.002156223],"genre_scores_gemma":[0.99760675,0.001195962,0.00009169533,0.00020477743,0.00061825034,0.000008055573,0.000057900477,0.00003855952,0.00017805248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974206,0.00050826755,0.00079905195,0.00030809475,0.0006567388,0.00030723674],"domain_scores_gemma":[0.9974363,0.00033378616,0.0007769846,0.00032846697,0.0010113064,0.000113150585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005923122,0.00025966496,0.00066505704,0.0003992116,0.0001292228,0.0000621133,0.00026480187,0.00007210072,0.0006468453],"category_scores_gemma":[0.00028685946,0.00021382635,0.0006099167,0.00064306555,0.00015633284,0.0004331392,0.00008399256,0.0010676396,0.000021888998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021043804,0.002299776,0.9441133,0.0005530353,0.00130932,0.001774946,0.029136728,0.00894495,0.0018978381,0.00043899615,0.0011037702,0.0063229203],"study_design_scores_gemma":[0.009578422,0.00018576418,0.49944875,0.0003276246,0.00061682303,0.00035332525,0.48349452,0.0012582326,0.00006008416,0.0000657503,0.0043519624,0.00025875866],"about_ca_topic_score_codex":0.0020070125,"about_ca_topic_score_gemma":0.0014050732,"teacher_disagreement_score":0.4543578,"about_ca_system_score_codex":0.00060940575,"about_ca_system_score_gemma":0.00039687453,"threshold_uncertainty_score":0.87195855},"labels":[],"label_agreement":null},{"id":"W4210450301","doi":"10.18553/jmcp.2022.28.2.157","title":"Burden of hospitalization for heart failure in the United States: a systematic literature review","year":2022,"lang":"en","type":"review","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Broadcom (Canada)","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Indirect costs; MEDLINE; Diabetes mellitus; Systematic review; Internal medicine; Demography; Emergency medicine; Endocrinology","score_opus":0.04177637764311661,"score_gpt":0.36971123086539215,"score_spread":0.32793485322227556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210450301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067300743,0.98722255,0.000031515738,0.0040011145,0.00033228254,0.0081865145,0.00006578932,0.000010359814,0.00014311734],"genre_scores_gemma":[0.000016119096,0.9963041,0.00039344022,0.0009665179,0.00077279937,0.00036192013,0.0009427252,0.000059185448,0.0001832112],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955122,0.0010900253,0.001970272,0.00024250317,0.0009164786,0.00026855283],"domain_scores_gemma":[0.9969142,0.00044712235,0.0016538481,0.00046383965,0.00041882304,0.00010213541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00204993,0.00043994398,0.003105318,0.0009883092,0.000089058354,0.00006478219,0.00046306904,0.000078577796,0.00021199095],"category_scores_gemma":[0.00034219967,0.00025711115,0.0013555767,0.0018057607,0.000026704189,0.00011559008,0.00007286863,0.00079815404,0.000004298177],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046269364,0.00013100261,0.000003691073,0.8624593,0.0007205864,0.00037803993,0.0021018975,0.0000099791705,7.1830556e-8,0.00007686199,0.10962495,0.024447322],"study_design_scores_gemma":[0.001074562,0.0002452472,6.3089374e-7,0.3189321,0.0070736716,0.00021940611,0.0014359424,0.0000044511457,1.2440225e-7,0.0000058137316,0.67088383,0.00012424542],"about_ca_topic_score_codex":0.000016397336,"about_ca_topic_score_gemma":0.000012611892,"teacher_disagreement_score":0.56125885,"about_ca_system_score_codex":0.0004989083,"about_ca_system_score_gemma":0.00027277705,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W4226088426","doi":"10.18553/jmcp.2022.28.2.146","title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"National Institute for Health and Care Research","keywords":"Checklist; Economic evaluation; Context (archaeology); Health care; Public health; Stakeholder; Public relations; Medicine; Guideline; Political science; Psychology; Nursing; Law","score_opus":0.29192687209551105,"score_gpt":0.5341751292409163,"score_spread":0.2422482571454052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226088426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6540689,0.04708554,0.013943615,0.2185913,0.02482388,0.01500171,0.019075356,0.00025357475,0.007156123],"genre_scores_gemma":[0.96741897,0.0019098396,0.005814636,0.017533865,0.0037999388,0.0008496825,0.0017808417,0.0002482867,0.000643925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96133196,0.0028231046,0.032579254,0.0011659258,0.00094699365,0.0011527663],"domain_scores_gemma":[0.9029836,0.00059612334,0.09416906,0.00079174066,0.0009102256,0.00054923503],"candidate_categories":["metaresearch","metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19974998,0.0004839573,0.0027254832,0.0012573969,0.0020466843,0.000283684,0.000778911,0.000074838295,0.0059505426],"category_scores_gemma":[0.010201282,0.00067418447,0.00070588454,0.0004008261,0.000086052525,0.0010299195,0.00023303705,0.0009232095,0.00008670233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00054893957,0.00022627416,0.011984726,0.0010372375,0.0010039106,0.000020845082,0.0129381735,0.10394054,0.00003074759,0.0053521353,0.849513,0.013403493],"study_design_scores_gemma":[0.009332765,0.00078018097,0.0047792504,0.000208126,0.0001529671,0.00016507403,0.020650169,0.04464863,0.00006700126,0.0041361973,0.91412437,0.0009552635],"about_ca_topic_score_codex":0.0015371186,"about_ca_topic_score_gemma":0.0013128307,"teacher_disagreement_score":0.31335008,"about_ca_system_score_codex":0.031789787,"about_ca_system_score_gemma":0.011583259,"threshold_uncertainty_score":0.9995709},"labels":[],"label_agreement":null},{"id":"W4245507582","doi":"10.18553/jmcp.2020.26.1.55","title":"AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection","year":2019,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Defense Health Agency; University of Massachusetts Medical School; U.S. Food and Drug Administration; National Pharmaceutical Council; Mallinckrodt Pharmaceuticals; American Pharmacists Association; Ohio State University; Case Western Reserve University; National Psoriasis Foundation","keywords":"Prior authorization; Authorization; General partnership; Selection (genetic algorithm); Legislature; Medicine; Political science; Computer science; Pharmacology; Computer security; Artificial intelligence; Law","score_opus":0.20727745877756928,"score_gpt":0.43419884096173844,"score_spread":0.22692138218416916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245507582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46402302,0.0063709365,0.40453258,0.080746375,0.013405719,0.006914863,0.00017799808,0.00017296219,0.023655549],"genre_scores_gemma":[0.97995055,0.0003561187,0.0122279925,0.0031172573,0.0034400327,0.000053551532,0.000048855745,0.000060376227,0.0007452675],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.995218,0.0002932844,0.0035236098,0.00036861986,0.00021878938,0.00037774295],"domain_scores_gemma":[0.9938886,0.00044333504,0.004885913,0.00021020204,0.00036912432,0.00020279194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010533503,0.00019426184,0.00083291397,0.00056203996,0.00024231998,0.00013318955,0.0003170987,0.00010641346,0.00044393455],"category_scores_gemma":[0.0015012657,0.00023323965,0.00027829182,0.000271409,0.000025552557,0.0008594365,0.00003196863,0.0003301337,0.00030671907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017166282,0.0006280477,0.18859452,0.0066476976,0.001364275,0.000007996395,0.030626798,0.019602552,0.0007018608,0.49741927,0.19912545,0.053564906],"study_design_scores_gemma":[0.010969629,0.0005321184,0.015504421,0.00039382954,0.00017144455,0.00003852612,0.011789792,0.040377706,0.00058619236,0.017242517,0.90144557,0.000948234],"about_ca_topic_score_codex":0.000055132146,"about_ca_topic_score_gemma":0.000046805824,"teacher_disagreement_score":0.70232016,"about_ca_system_score_codex":0.001075079,"about_ca_system_score_gemma":0.00026515004,"threshold_uncertainty_score":0.9511237},"labels":[],"label_agreement":null},{"id":"W4293102417","doi":"10.18553/jmcp.2022.28.9.958","title":"Treatment persistence and adherence in people with type 2 diabetes switching to iGlarLixi vs free-dose combinations of basal insulin and glucagon-like peptide 1 receptor agonist","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Basal insulin; Persistence (discontinuity); Agonist; Type 2 diabetes; Basal (medicine); Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Insulin; Endocrinology; Internal medicine; Receptor; Diabetes mellitus","score_opus":0.01925624183233251,"score_gpt":0.2697511568846674,"score_spread":0.2504949150523349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293102417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389416,0.0020835986,0.0000056827967,0.0018322087,0.00030081897,0.000642889,0.000024162855,0.000009502713,0.0012069861],"genre_scores_gemma":[0.9969043,0.0011389364,0.0010266993,0.00034270156,0.00010627197,0.00003542897,0.000017810584,0.000022984705,0.00040484563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985755,0.00011002463,0.0003992828,0.0002367144,0.0004371348,0.00024131642],"domain_scores_gemma":[0.99906296,0.00009438018,0.00028095616,0.00019900814,0.00016752705,0.00019515079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002547133,0.00020290198,0.0004975266,0.0003725489,0.00018407012,0.00004783954,0.00016985576,0.000013799328,0.00013483428],"category_scores_gemma":[0.000053517975,0.00016858456,0.000081439124,0.000459001,0.000045077453,0.00015901025,0.0001973315,0.00024264654,0.0000019307122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005741909,0.003933045,0.8037912,0.0007752898,0.0015343437,0.000606212,0.029831259,0.00038549263,0.005911031,0.00030011943,0.006504295,0.14068577],"study_design_scores_gemma":[0.07104764,0.026847836,0.69797397,0.0009805823,0.0031087578,0.00009249738,0.049837112,0.00057091034,0.0050800233,0.00017134096,0.14330085,0.0009884776],"about_ca_topic_score_codex":0.00018747558,"about_ca_topic_score_gemma":0.0004954643,"teacher_disagreement_score":0.13969728,"about_ca_system_score_codex":0.00046275428,"about_ca_system_score_gemma":0.00014875898,"threshold_uncertainty_score":0.68746793},"labels":[],"label_agreement":null},{"id":"W4307427140","doi":"10.18553/jmcp.2022.28.11.1213","title":"COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Coronavirus disease 2019 (COVID-19); Pharmacy; Medicine; 2019-20 coronavirus outbreak; MEDLINE; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Psoriasis; Family medicine; Virology; Dermatology; Disease; Internal medicine; Infectious disease (medical specialty); Political science","score_opus":0.09957264582041192,"score_gpt":0.3783236926464389,"score_spread":0.27875104682602697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307427140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98046774,0.013230606,0.00058070006,0.0011282436,0.0015617427,0.00059138867,0.0023013172,0.000025226207,0.00011305166],"genre_scores_gemma":[0.99554145,0.0016033627,0.00055553345,0.0011035015,0.00027913143,0.000045777324,0.0006921645,0.000016867209,0.00016222692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780107,0.00073398586,0.00066512986,0.00039132274,0.00013925435,0.00026924512],"domain_scores_gemma":[0.9981054,0.000431893,0.0006790154,0.00041193224,0.00023408183,0.00013765336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001233119,0.00022243301,0.0006488604,0.00078636856,0.0005044479,0.00002933794,0.0009759555,0.000041585266,0.0016249812],"category_scores_gemma":[0.00022406982,0.00019056369,0.0002605725,0.00072401145,0.00008757773,0.00024403268,0.000308398,0.00024235889,0.0000038366456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015012586,0.0014035531,0.12382832,0.00028921288,0.024714276,0.00014778256,0.024338594,0.0025903087,0.117132105,0.0009243524,0.025261063,0.66435784],"study_design_scores_gemma":[0.017123748,0.0021556532,0.024899222,0.000018695217,0.01249515,0.0001175374,0.021726198,0.00014973461,0.011863556,0.00047737433,0.90831614,0.0006569707],"about_ca_topic_score_codex":0.00021207752,"about_ca_topic_score_gemma":0.0003730078,"teacher_disagreement_score":0.8830551,"about_ca_system_score_codex":0.00016933828,"about_ca_system_score_gemma":0.0002970765,"threshold_uncertainty_score":0.99928766},"labels":[],"label_agreement":null},{"id":"W4310049761","doi":"10.18553/jmcp.2022.28.12.1410","title":"Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hyperkalemia; Prior authorization; Intensive care medicine; Kidney disease; Formulary; Medical emergency; Family medicine; Nursing; Internal medicine","score_opus":0.027327840231749456,"score_gpt":0.3605037094673068,"score_spread":0.33317586923555736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310049761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95916176,0.02621795,0.0021808345,0.0061139897,0.002317303,0.0022647392,0.00017518461,0.00005395699,0.0015142573],"genre_scores_gemma":[0.9967784,0.000776395,0.0011357468,0.00056032016,0.00051804405,0.000027982427,0.00012203109,0.000028129545,0.00005294707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975518,0.00044492964,0.001142491,0.00022270369,0.0004153151,0.00022278212],"domain_scores_gemma":[0.998302,0.00013532025,0.00097444566,0.000118980264,0.00029363955,0.00017563954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008200437,0.00013130235,0.00042944364,0.0002725403,0.00031177708,0.0000272097,0.000120745804,0.000053113472,0.000022323711],"category_scores_gemma":[0.00028432423,0.00012355477,0.00012771993,0.00029693232,0.0000301108,0.00010363727,0.000046834088,0.00068917795,6.399172e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006158436,0.0009410513,0.20875674,0.0059534973,0.0005740547,0.0004592471,0.034374416,0.0005669325,0.0013841229,0.00056043104,0.08660426,0.6536668],"study_design_scores_gemma":[0.061954282,0.004118123,0.42079642,0.0018822231,0.0019636573,0.00052037946,0.11813084,0.0073223,0.00023383119,0.00008039922,0.38209593,0.0009016072],"about_ca_topic_score_codex":0.00008571673,"about_ca_topic_score_gemma":0.00003079118,"teacher_disagreement_score":0.6527652,"about_ca_system_score_codex":0.00079842925,"about_ca_system_score_gemma":0.00045243098,"threshold_uncertainty_score":0.5038417},"labels":[],"label_agreement":null},{"id":"W4310050139","doi":"10.18553/jmcp.2022.28.12.1392","title":"A dynamic analysis of medication adherence","year":2022,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medication adherence; Medicine; Medical prescription; Observational study; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.03377093411223851,"score_gpt":0.3632091920977731,"score_spread":0.32943825798553455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310050139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736754,0.0039855763,0.002784292,0.0038195637,0.0011314434,0.0003951671,0.000037717185,0.000020601177,0.01415025],"genre_scores_gemma":[0.99681705,0.0006311778,0.00056012935,0.0007967242,0.00016386737,0.000012917315,0.000032027692,0.000009369064,0.0009767165],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977704,0.00014420702,0.0007096191,0.00014956298,0.0010859497,0.00014023183],"domain_scores_gemma":[0.99812996,0.00006452268,0.00097517617,0.00027015407,0.00039195307,0.00016821876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006001961,0.00010150711,0.00048370837,0.0006275221,0.00010404179,0.00000778065,0.00036177342,0.00001658645,0.010771087],"category_scores_gemma":[0.00011126158,0.000093225266,0.00033151804,0.0013799554,0.00006149065,0.000076035205,0.000069495225,0.00047728588,0.000025325888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045490484,0.0023740972,0.19371778,0.0012501035,0.012206844,0.0012894896,0.014807873,0.003131654,0.046403337,0.0012424707,0.10226565,0.6167617],"study_design_scores_gemma":[0.010680632,0.0015555256,0.49163336,0.00029110417,0.014659105,0.00037724464,0.021469308,0.0089991065,0.0027537537,0.00036455193,0.44672754,0.0004887616],"about_ca_topic_score_codex":0.000028758226,"about_ca_topic_score_gemma":0.000014268594,"teacher_disagreement_score":0.6162729,"about_ca_system_score_codex":0.00025468427,"about_ca_system_score_gemma":0.00036714852,"threshold_uncertainty_score":0.9901332},"labels":[],"label_agreement":null},{"id":"W4367550171","doi":"10.18553/jmcp.2023.29.5.499","title":"Place of care and costs associated with acute episodes and remission in schizophrenia","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Clozapine; Schizophrenia (object-oriented programming); Emergency department; Acute care; Inpatient care; Diagnosis of schizophrenia; Psychiatry; Antipsychotic; Ambulatory care; Managed care; Emergency medicine; Health care; Pediatrics; Psychosis","score_opus":0.017100901820344166,"score_gpt":0.3222262041200625,"score_spread":0.3051253022997183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367550171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938568,0.004109023,0.0000013590221,0.00085397117,0.00007015528,0.00032674408,0.000028311833,0.000015286036,0.00073834346],"genre_scores_gemma":[0.9937801,0.0053715613,0.00050774927,0.000032445714,0.00016605132,0.0000038417093,0.000023433984,0.000022292914,0.00009253613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99850416,0.00013459637,0.00035356169,0.0001781266,0.0005776717,0.0002518554],"domain_scores_gemma":[0.9988484,0.00018462136,0.00024304636,0.00011805901,0.00031389494,0.0002920196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033598894,0.00016298522,0.00048057147,0.00046831378,0.000074782525,0.000028052136,0.0000881416,0.00004451923,0.000028641429],"category_scores_gemma":[0.00020471426,0.00011614482,0.00007472106,0.00051552185,0.00008325722,0.00011826208,0.00007336426,0.00043729716,0.0000019927468],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1162629,0.00038363686,0.35422745,0.00094886695,0.0020593589,0.019847553,0.0073490175,0.000041408606,0.007198239,0.00015585944,0.0043614455,0.48716426],"study_design_scores_gemma":[0.06537583,0.0029386233,0.9048043,0.003192857,0.0010549038,0.00058447965,0.007912456,0.00014138236,0.012005872,0.00012294117,0.0015559252,0.00031044957],"about_ca_topic_score_codex":0.000061834675,"about_ca_topic_score_gemma":0.00064051535,"teacher_disagreement_score":0.5505768,"about_ca_system_score_codex":0.00033835592,"about_ca_system_score_gemma":0.0002907867,"threshold_uncertainty_score":0.47362483},"labels":[],"label_agreement":null},{"id":"W4378549192","doi":"10.18553/jmcp.2023.22417","title":"Identifying potentially undiagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease: Development of a predictive algorithm using claims data","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Insmed","keywords":"Medicine; COPD; Comorbidity; Chronic bronchitis; Internal medicine; Retrospective cohort study; Bronchiectasis; Obstructive lung disease; Cohort; Logistic regression; Intensive care medicine; Lung","score_opus":0.030648692227508868,"score_gpt":0.32172441483576236,"score_spread":0.2910757226082535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378549192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994004,0.00080044527,0.0014804086,0.00007792993,0.0012534359,0.0012956163,0.0009707793,0.00004336698,0.000074010604],"genre_scores_gemma":[0.9932663,0.000604566,0.0022846381,0.000030860363,0.0023955419,0.00002524778,0.0012831091,0.00008286034,0.000026866179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954993,0.0002439399,0.0010233879,0.0005634659,0.0019938326,0.0006760358],"domain_scores_gemma":[0.9961432,0.00015755054,0.00083663367,0.00061676005,0.0010867104,0.0011591448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005145828,0.00038965477,0.00070794165,0.00069769204,0.0003141574,0.00012874468,0.0006862562,0.000057028403,0.00026563203],"category_scores_gemma":[0.00026962403,0.00033069335,0.00024455972,0.00079481327,0.00018837815,0.0010189742,0.0006289466,0.0005927538,0.000008713463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009644797,0.00075960945,0.8910443,0.0018754677,0.0015633033,0.0068141636,0.0011792189,0.0002624632,0.000981485,0.0000024850024,0.00096251926,0.08491016],"study_design_scores_gemma":[0.0062416303,0.00015178515,0.98541766,0.001352557,0.0016133494,0.000018023742,0.00043778305,0.0031244196,0.00036408365,0.00001902978,0.00094729906,0.00031235535],"about_ca_topic_score_codex":0.00008153721,"about_ca_topic_score_gemma":0.000051711904,"teacher_disagreement_score":0.09437336,"about_ca_system_score_codex":0.0011917272,"about_ca_system_score_gemma":0.002419593,"threshold_uncertainty_score":0.9999145},"labels":[],"label_agreement":null},{"id":"W4379390237","doi":"10.18553/jmcp.2023.29.6.671","title":"Pharmacists’ chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; COPD; Pulmonary disease; Disease management; Emergency department; Pharmacist; Pulmonary function testing; Emergency medicine; Health care; Disease; Internal medicine; Physical therapy; Family medicine; Pharmacy; Nursing","score_opus":0.028798097865915858,"score_gpt":0.369254444798583,"score_spread":0.34045634693266713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379390237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8835926,0.092835866,0.00002624733,0.00559731,0.004720624,0.0030964764,0.00016991956,0.00019745855,0.009763474],"genre_scores_gemma":[0.9407482,0.055273425,0.000010176453,0.00070078205,0.0026867841,0.00004578246,0.00014419884,0.00005223159,0.00033841384],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971173,0.00027950015,0.0007494043,0.00040434045,0.0009040699,0.0005454054],"domain_scores_gemma":[0.99848396,0.00007799921,0.00043494685,0.00028672538,0.00020046967,0.00051587884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048523393,0.00036118293,0.0006010678,0.0007230168,0.0002422178,0.000028839306,0.00028524676,0.000026070024,0.00020778862],"category_scores_gemma":[0.00003151412,0.00031137248,0.00033722408,0.0011437178,0.00006460064,0.00023735469,0.00014644743,0.0005301664,0.00006376745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009081464,0.0004804667,0.03722148,0.025332404,0.0012505808,0.021577263,0.0023653153,0.0033054021,0.0004860122,0.00040112578,0.024019368,0.8744791],"study_design_scores_gemma":[0.013232215,0.0011738329,0.72763777,0.004453009,0.001645316,0.000058162415,0.0026738485,0.0019135384,0.0007908019,0.0004068883,0.2452961,0.0007185],"about_ca_topic_score_codex":0.0000111151085,"about_ca_topic_score_gemma":0.000027953225,"teacher_disagreement_score":0.87376064,"about_ca_system_score_codex":0.0021565852,"about_ca_system_score_gemma":0.00040188603,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W4380319259","doi":"10.18553/jmcp.2023.23013","title":"Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Indirect costs; Gerontology; Total cost; Medicaid; Demography; Health care","score_opus":0.4449090573847032,"score_gpt":0.4941077475740367,"score_spread":0.04919869018933348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380319259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401183,0.014169744,0.0003440352,0.04172374,0.0016897911,0.001127362,0.00025710257,0.000015018582,0.0005549226],"genre_scores_gemma":[0.98949635,0.00261055,0.0001679811,0.006553403,0.0010083751,0.000044947777,0.00004031541,0.000028474662,0.000049612554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642104,0.00060556305,0.0023295041,0.00020249587,0.00015659498,0.00028482426],"domain_scores_gemma":[0.99302846,0.0041887453,0.00226656,0.00023614788,0.0001631261,0.00011696229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014034002,0.00015174951,0.00063578936,0.0005681025,0.00024227635,0.00022608168,0.00041218472,0.000032753334,0.00006727459],"category_scores_gemma":[0.0021033445,0.00012129789,0.00016430118,0.00038845072,0.0000918376,0.00047154145,0.000052677486,0.00026770524,0.000024352761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086403853,0.0003381439,0.320702,0.0014518406,0.0013493976,0.00011816654,0.09370628,0.0020587328,0.000019585006,0.00824172,0.54324055,0.027909562],"study_design_scores_gemma":[0.0043486627,0.000091331705,0.3474606,0.000310682,0.00023144433,0.000007690727,0.07470749,0.0044192756,0.000049391318,0.0047402345,0.5632438,0.00038936076],"about_ca_topic_score_codex":0.00023661045,"about_ca_topic_score_gemma":0.0002496445,"teacher_disagreement_score":0.049378056,"about_ca_system_score_codex":0.00017368021,"about_ca_system_score_gemma":0.00012476758,"threshold_uncertainty_score":0.49463844},"labels":[],"label_agreement":null},{"id":"W4383186570","doi":"10.18553/jmcp.2023.29.7.758","title":"Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Olaparib; Cohort; Taxane; Breast cancer; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.09824664513683765,"score_gpt":0.43613664796998347,"score_spread":0.33789000283314585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383186570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935327,0.0014493119,0.0000098202145,0.00048725386,0.00025092304,0.0039105103,0.00032088446,0.000015801364,0.000022785947],"genre_scores_gemma":[0.99825907,0.0006166012,0.0006105233,0.00020593956,0.00008179224,0.00011769936,0.000045799392,0.000037136717,0.000025420839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964814,0.00040954168,0.0018524162,0.000271965,0.0006987091,0.00028596199],"domain_scores_gemma":[0.99652046,0.00021337744,0.0019535725,0.00020454817,0.0008641393,0.00024387764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013248475,0.00021983222,0.001123779,0.0004196611,0.000093951,0.000025000254,0.00016210217,0.0000236102,0.000032793934],"category_scores_gemma":[0.00017414175,0.00018146247,0.00009406948,0.0006580104,0.00007831452,0.0002544252,0.000050624218,0.0002695027,4.2327474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16966929,0.024339968,0.6960234,0.007482384,0.0044404226,0.00035005683,0.047997195,0.0010018955,0.02556226,0.00004183258,0.0046863058,0.018404998],"study_design_scores_gemma":[0.46566,0.015267184,0.49749583,0.0017483776,0.0009954161,0.000009785077,0.012545745,0.00027156062,0.004659743,0.00005359843,0.0008676014,0.0004251435],"about_ca_topic_score_codex":0.0012832412,"about_ca_topic_score_gemma":0.0023011041,"teacher_disagreement_score":0.29599074,"about_ca_system_score_codex":0.00034767826,"about_ca_system_score_gemma":0.00068092614,"threshold_uncertainty_score":0.7399825},"labels":[],"label_agreement":null},{"id":"W4385415391","doi":"10.18553/jmcp.2023.29.8.896","title":"Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Major depressive disorder; Adjunctive treatment; Psychiatry; Resource use; Bipolar disorder; Schizophrenia (object-oriented programming); MEDLINE; Health care; Mood","score_opus":0.04567015405411958,"score_gpt":0.3411468752849681,"score_spread":0.29547672123084856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385415391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211687,0.0038697836,0.000022112801,0.0020499523,0.00017091898,0.0014489678,0.00018489327,0.000038844104,0.000097659125],"genre_scores_gemma":[0.9905236,0.008437925,0.00010133696,0.00016976282,0.00018576001,0.000029669887,0.00034314184,0.00006477358,0.00014405069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732274,0.00035554828,0.00078416796,0.00040127354,0.0007245252,0.0004117623],"domain_scores_gemma":[0.99781156,0.0003172208,0.0008214519,0.00030586106,0.00040162864,0.00034229207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000132822,0.00040177777,0.00093573146,0.00051772787,0.00017458889,0.00004491285,0.00010482391,0.000087137385,0.000047251993],"category_scores_gemma":[0.00013733811,0.0002809353,0.00019271272,0.000533573,0.00008801206,0.00018345154,0.00005147897,0.00026407026,0.0000033938409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014854553,0.0012783303,0.9203338,0.00019516957,0.00084467034,0.001984317,0.008645613,0.0003022983,0.00002364672,0.000011762843,0.0009832362,0.05054262],"study_design_scores_gemma":[0.032938853,0.0047348067,0.937832,0.0014363802,0.00083286647,0.00011574108,0.0050752433,0.00006646967,0.0009179687,0.0000042334354,0.015828008,0.00021744629],"about_ca_topic_score_codex":0.0007526251,"about_ca_topic_score_gemma":0.006007938,"teacher_disagreement_score":0.050325174,"about_ca_system_score_codex":0.0025533382,"about_ca_system_score_gemma":0.00036089748,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W4386084628","doi":"10.18553/jmcp.2023.29.9.1045","title":"Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Ejection fraction; Heart failure with preserved ejection fraction; Cost effectiveness; Hazard ratio; Heart failure; Intensive care medicine; Internal medicine; Emergency medicine; Diabetes mellitus; Type 2 diabetes; Risk analysis (engineering); Confidence interval","score_opus":0.026722205193785323,"score_gpt":0.3308528337624001,"score_spread":0.3041306285686148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740416,0.000160074,0.00007842924,0.0003423296,0.00016537719,0.0011839069,0.00001516381,0.00002065648,0.00062991184],"genre_scores_gemma":[0.99921143,0.00008467052,0.00029790582,0.000064646585,0.00017210579,0.000029022933,0.000059616876,0.000017918625,0.00006265553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981053,0.00030816928,0.0004926991,0.00024083172,0.0006155995,0.00023740312],"domain_scores_gemma":[0.99868375,0.00015344721,0.00040561458,0.00018500318,0.0004291033,0.00014308695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005295064,0.00021298659,0.0009284921,0.001169914,0.00007066517,0.000036689853,0.000093939016,0.00003888026,0.000073223506],"category_scores_gemma":[0.000039446353,0.00016876105,0.00021740352,0.0017881874,0.000057993573,0.00032109633,0.00006283946,0.0003035755,0.0000057984566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035754072,0.00045989384,0.9876306,0.0003009456,0.0025382875,0.000059801143,0.00041101407,0.0021094242,0.000123816,0.000018889526,0.0017306703,0.001041258],"study_design_scores_gemma":[0.011267586,0.00094761857,0.9728688,0.00023907878,0.0030037968,0.0000013885149,0.0014836265,0.00032425908,0.0014279714,0.000018606788,0.008278954,0.0001383078],"about_ca_topic_score_codex":0.000086325366,"about_ca_topic_score_gemma":0.00020083638,"teacher_disagreement_score":0.014761786,"about_ca_system_score_codex":0.0003184417,"about_ca_system_score_gemma":0.000060423976,"threshold_uncertainty_score":0.6881876},"labels":[],"label_agreement":null},{"id":"W4396723201","doi":"10.18553/jmcp.2024.23324","title":"Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Lupus nephritis; Medicine; MEDLINE; Intensive care medicine; Internal medicine; Disease; Political science","score_opus":0.1251450861698361,"score_gpt":0.4600347434019011,"score_spread":0.334889657232065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396723201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717175,0.021423945,0.00014991207,0.0018727671,0.0010178204,0.0034679284,0.000044606455,0.0000070878773,0.00029846982],"genre_scores_gemma":[0.9922485,0.0063649644,0.000066097535,0.000061248706,0.0009240712,0.00014857308,0.00001509828,0.00003166302,0.00013980005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677473,0.0010462585,0.00076093903,0.00015364317,0.001001486,0.00026292665],"domain_scores_gemma":[0.9928186,0.0058085714,0.000323789,0.00033032347,0.0006613189,0.000057408877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004263932,0.00017545982,0.0005188022,0.00033891274,0.00010725683,0.000052000243,0.0004200083,0.000032457454,0.00004755301],"category_scores_gemma":[0.00035395304,0.000076298245,0.00038568414,0.00084203354,0.00014013129,0.000070050555,0.0000333607,0.00037558915,0.000002233875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020745259,0.0017014091,0.09399626,0.019086948,0.005149891,0.0018661749,0.19144642,0.006693753,0.013540893,0.0016830002,0.009709854,0.63438016],"study_design_scores_gemma":[0.060859997,0.0135474615,0.02848674,0.016781934,0.0063305553,0.0161309,0.3174323,0.029012771,0.04324438,0.0017642748,0.46575007,0.000658597],"about_ca_topic_score_codex":0.00034609545,"about_ca_topic_score_gemma":0.00008875247,"teacher_disagreement_score":0.63372153,"about_ca_system_score_codex":0.000552151,"about_ca_system_score_gemma":0.00033237142,"threshold_uncertainty_score":0.3111352},"labels":[],"label_agreement":null},{"id":"W4401392934","doi":"10.18553/jmcp.2024.24025","title":"Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Diabetes mellitus; Perspective (graphical); Medicine; Continuous glucose monitoring; Microsimulation; Basal insulin; Insulin; Type 2 diabetes; Blood Glucose Self-Monitoring; Type 2 Diabetes Mellitus; Basal (medicine); Type 1 diabetes; Intensive care medicine; Internal medicine; Computer science; Endocrinology; Engineering","score_opus":0.01961952572042414,"score_gpt":0.33435348394074993,"score_spread":0.3147339582203258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401392934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885227,0.008618202,0.0004623966,0.00024939573,0.00015998201,0.0017025736,0.000019137471,0.000025083096,0.00024053233],"genre_scores_gemma":[0.9950242,0.002446299,0.0019971249,0.000061939194,0.0003051508,0.00007363032,0.000008082836,0.00004685318,0.000036744532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980176,0.00015009267,0.00039920732,0.0003995344,0.0006795517,0.00035402714],"domain_scores_gemma":[0.99810123,0.0007771505,0.00019442514,0.00019025271,0.00057036406,0.00016656872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008589797,0.00025044126,0.0007365512,0.0009148344,0.00007067096,0.000104054576,0.00016572134,0.00003991835,0.0000130471735],"category_scores_gemma":[0.00008556797,0.0001807358,0.00015143216,0.0013971683,0.00004980034,0.00020641423,0.00007121665,0.0003603944,9.86487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006851906,0.0008950289,0.826927,0.002647027,0.0112480335,0.00017706043,0.009991637,0.044282462,0.0051263813,0.00011222319,0.0000696449,0.091671616],"study_design_scores_gemma":[0.01382271,0.0037015658,0.8883466,0.0077289725,0.0050804727,6.5145554e-7,0.0052096425,0.06172021,0.012461733,0.00019850851,0.0011879529,0.0005409414],"about_ca_topic_score_codex":0.00004511391,"about_ca_topic_score_gemma":0.000075979166,"teacher_disagreement_score":0.091130674,"about_ca_system_score_codex":0.0004913694,"about_ca_system_score_gemma":0.00010401453,"threshold_uncertainty_score":0.73701924},"labels":[],"label_agreement":null},{"id":"W4402830730","doi":"10.18553/jmcp.2024.30.10.1136","title":"A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Allergan; Bausch Health; Takeda Pharmaceuticals U.S.A.; Coloplast; University of Miami; Alnylam Pharmaceuticals","keywords":"Persistence (discontinuity); Medicine; Medical prescription; Medication adherence; Constipation; Real world evidence; Chronic disease; Family medicine; Internal medicine; Nursing","score_opus":0.031667870013039896,"score_gpt":0.3199147153283446,"score_spread":0.2882468453153047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402830730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782217,0.0003376257,0.00005768985,0.0007765773,0.000072486204,0.000712092,0.000004183688,0.000005229333,0.00021196136],"genre_scores_gemma":[0.99960846,0.00014660739,0.00006766707,0.00008483208,0.000058880014,0.000010277747,0.000008857702,0.000005850411,0.0000085940455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987543,0.00018838864,0.00040559832,0.00012626174,0.00041730594,0.00010813359],"domain_scores_gemma":[0.9993545,0.00008674231,0.00013934901,0.000102107406,0.00025062088,0.00006668173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005129537,0.000086799446,0.00019203448,0.00055847765,0.000034227258,0.000025560625,0.00010462454,0.000009842364,0.000016747797],"category_scores_gemma":[0.00012485287,0.00005914895,0.000027254218,0.00088651734,0.00006419307,0.00012334528,0.000019339132,0.00035662667,7.955277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011046821,0.00060991547,0.96250325,0.00045956927,0.000042760734,0.000096130774,0.026925119,0.00074221485,0.000056340188,0.000038567385,0.000114071954,0.007307363],"study_design_scores_gemma":[0.0034652702,0.0025917008,0.9710012,0.0013814577,0.0001861574,0.0000128349675,0.020636557,0.00041960346,0.000008029059,0.000025654826,0.00022397825,0.00004757021],"about_ca_topic_score_codex":0.0011235403,"about_ca_topic_score_gemma":0.008238118,"teacher_disagreement_score":0.008497921,"about_ca_system_score_codex":0.00018793564,"about_ca_system_score_gemma":0.00017391387,"threshold_uncertainty_score":0.4597063},"labels":[],"label_agreement":null},{"id":"W4403862361","doi":"10.18553/jmcp.2024.30.11.1318","title":"Unlocking the potential of digital therapeutics: The need for consistent and granular inclusion in drug compendia for managed care","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Drug; Medicine; Inclusion (mineral); MEDLINE; Medical emergency; Drug approval; Intensive care medicine; Pharmacology; Psychology; Chemistry","score_opus":0.03273581422332697,"score_gpt":0.37809850193007616,"score_spread":0.34536268770674916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403862361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89979297,0.050857134,0.0023417163,0.019041872,0.011335245,0.0049817422,0.0009430591,0.000050296436,0.010655965],"genre_scores_gemma":[0.998404,0.00010223011,0.00007848563,0.0004452644,0.0006103881,0.000046450215,0.00002579521,0.000039721293,0.0002476126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804944,0.00018705042,0.0008754593,0.00021677601,0.00036376977,0.00030751523],"domain_scores_gemma":[0.9985989,0.00052536675,0.00037410652,0.00020608764,0.00021961427,0.000075946125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077493663,0.00019531843,0.0003363637,0.00026291693,0.00038173088,0.00023748288,0.00050554815,0.00003935376,0.000041185696],"category_scores_gemma":[0.000027476195,0.00012720814,0.00047455184,0.00021752238,0.00015748185,0.00023968593,0.0003699359,0.00041382934,0.0000032815967],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037232256,0.00053595897,0.0015378225,0.0033587483,0.001156504,0.00034244658,0.056455474,0.00016627878,0.00044653425,0.02117369,0.009467863,0.90163547],"study_design_scores_gemma":[0.020619765,0.0018489014,0.012610449,0.002885593,0.002455949,0.0005188563,0.21345483,0.0011400782,0.0023882627,0.0399322,0.70126224,0.000882873],"about_ca_topic_score_codex":0.00005937812,"about_ca_topic_score_gemma":0.00020566316,"teacher_disagreement_score":0.9007526,"about_ca_system_score_codex":0.00021497226,"about_ca_system_score_gemma":0.000064795284,"threshold_uncertainty_score":0.51873976},"labels":[],"label_agreement":null},{"id":"W4404850065","doi":"10.18553/jmcp.2024.30.12.1349","title":"Fear of missing out: Drug availability in the United States vs Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Agency for Healthcare Research and Quality","keywords":"Drug; MEDLINE; Medicine; Environmental health; Pharmacology; Political science; Law","score_opus":0.04763722699797736,"score_gpt":0.3059557295201401,"score_spread":0.25831850252216276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404850065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93992513,0.009182723,0.00007924083,0.02636973,0.0019995617,0.0002471783,0.00038850057,0.000009029517,0.021798894],"genre_scores_gemma":[0.99411887,0.0018081304,0.00006637029,0.0031711655,0.0006802252,0.0000017418761,0.000011345544,0.00002128317,0.0001208692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981169,0.00010102346,0.0011851512,0.00020445563,0.000101626814,0.0002908088],"domain_scores_gemma":[0.9988173,0.00032013224,0.00044459567,0.0002100494,0.00007668552,0.00013118923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016483084,0.0001618282,0.000482357,0.00041631464,0.000070539005,0.00014529297,0.00054048497,0.000027331522,0.0005553173],"category_scores_gemma":[0.00012350263,0.000142315,0.00019884047,0.00044167668,0.00007017101,0.00019587687,0.00005670438,0.00064013136,0.000031184794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011564111,0.0007197602,0.088631764,0.0039370516,0.0013076378,0.0020606106,0.06899616,0.012014345,0.000104935694,0.09697787,0.6625788,0.061514623],"study_design_scores_gemma":[0.00079841196,0.000023604834,0.005194257,0.00006887669,0.00003134948,0.000016338943,0.0011582471,0.0048528393,0.00019091756,0.008154355,0.97933185,0.00017897574],"about_ca_topic_score_codex":0.07210945,"about_ca_topic_score_gemma":0.06288425,"teacher_disagreement_score":0.316753,"about_ca_system_score_codex":0.00061029114,"about_ca_system_score_gemma":0.00031021526,"threshold_uncertainty_score":0.95421565},"labels":[],"label_agreement":null},{"id":"W4406526102","doi":"10.18553/jmcp.2025.24253","title":"Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus – An economic evaluation","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Diabetes Canada","funders":"","keywords":"Glucagon-like peptide 1 receptor; Medicine; Continuous glucose monitoring; Type 2 Diabetes Mellitus; Agonist; Diabetes mellitus; Glucagon-like peptide-1; Internal medicine; Type 2 diabetes; Endocrinology; Receptor; Type 1 diabetes","score_opus":0.05746476984958627,"score_gpt":0.4000279298708894,"score_spread":0.34256316002130316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406526102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763824,0.002953793,0.000043128723,0.00083668664,0.0031051943,0.0016340347,0.00004892943,0.000016528746,0.0037234537],"genre_scores_gemma":[0.99260545,0.0014419268,0.0012895121,0.000118468626,0.0026036047,0.00006601163,0.00013325331,0.000031985663,0.001709766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822223,0.00014819784,0.00062742503,0.0002420345,0.00043893588,0.0003211453],"domain_scores_gemma":[0.9982166,0.00013589283,0.00034956337,0.00025073157,0.0008452473,0.00020195969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097253954,0.00019501819,0.00053790875,0.0005550395,0.00012795534,0.000080537575,0.00021549899,0.000042898653,0.00035722446],"category_scores_gemma":[0.0001478033,0.00016973258,0.00026550604,0.00024535359,0.00004171183,0.00021680104,0.000050360588,0.000159834,0.000023165912],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002726498,0.0005279514,0.009198555,0.0005623496,0.001083186,0.000013253093,0.00077084155,0.0005359596,0.021703321,0.00009652117,0.024020594,0.938761],"study_design_scores_gemma":[0.015948933,0.004672433,0.020790596,0.0010109172,0.002821192,0.0000014645112,0.0034658413,0.0010475559,0.23665233,0.00023164455,0.7129932,0.00036389797],"about_ca_topic_score_codex":0.000022768412,"about_ca_topic_score_gemma":0.000026097736,"teacher_disagreement_score":0.93839705,"about_ca_system_score_codex":0.0011521012,"about_ca_system_score_gemma":0.00037644999,"threshold_uncertainty_score":0.69214934},"labels":[],"label_agreement":null},{"id":"W4410906154","doi":"10.18553/jmcp.2025.31.6.578","title":"Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Hereditary angioedema; Medicine; MEDLINE; Angioedema; Family medicine; Dermatology; Political science","score_opus":0.009725072763414408,"score_gpt":0.29833216811034863,"score_spread":0.28860709534693424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410906154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929581,0.0010738018,0.000064495995,0.0045174756,0.00034867317,0.00044850062,0.000006636518,0.000008573848,0.00057372404],"genre_scores_gemma":[0.9981388,0.00035260664,0.000090783185,0.0010281887,0.00023014896,0.000008611984,0.00011036937,0.00001335366,0.00002715332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825597,0.00019445349,0.0006364176,0.0001551782,0.00055281515,0.00020519315],"domain_scores_gemma":[0.99926996,0.00016940733,0.0001775711,0.0001102486,0.00018339964,0.000089390596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005298985,0.00014512586,0.000311026,0.00095131213,0.000097389326,0.000041964577,0.00012842573,0.0000522725,0.000036624948],"category_scores_gemma":[0.0001994444,0.00010924962,0.0000827633,0.0012410854,0.00005024084,0.0002584474,0.000028467062,0.0003776844,4.344396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034764304,0.00030671596,0.9821564,0.00008367536,0.000088564346,0.0003883897,0.0072624465,0.00052369956,0.0000030041554,0.0002290311,0.0010503021,0.007560142],"study_design_scores_gemma":[0.0076966668,0.00014704977,0.98265547,0.0008400407,0.00015307748,0.000021052601,0.005550081,0.00032108693,0.000025965965,0.00027455646,0.0022076378,0.00010734487],"about_ca_topic_score_codex":0.0003294072,"about_ca_topic_score_gemma":0.0012489767,"teacher_disagreement_score":0.007452797,"about_ca_system_score_codex":0.00018716222,"about_ca_system_score_gemma":0.00021141027,"threshold_uncertainty_score":0.44550702},"labels":[],"label_agreement":null},{"id":"W4412489576","doi":"10.18553/jmcp.2025.25051","title":"Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Obesity; Indirect costs; Weight loss; Observational study; Systematic review; Cohort study; Medical costs; MEDLINE; Cost–benefit analysis; Demography; Gerontology; Internal medicine; Health care","score_opus":0.014195685886307685,"score_gpt":0.31333427592544505,"score_spread":0.29913859003913734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412489576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52809477,0.44387513,0.000076652825,0.021045009,0.00068469025,0.0022577327,0.000027279213,0.000019644402,0.003919071],"genre_scores_gemma":[0.7953106,0.19806822,0.000065029315,0.0062572556,0.00011325686,0.000009100195,0.000040622548,0.000010292002,0.00012562318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974567,0.00075566414,0.0011129434,0.00013224085,0.00038876673,0.00015365842],"domain_scores_gemma":[0.99772537,0.00073503464,0.0006291178,0.00028851855,0.0005428211,0.000079115904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016412701,0.00016896527,0.0008435353,0.0006041047,0.00008399307,0.00003560582,0.0002746842,0.000051308794,0.000027775808],"category_scores_gemma":[0.0003649295,0.00010514395,0.00021705515,0.0017655905,0.000057293837,0.000108836095,0.000054295917,0.00067954895,0.000002607162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970555,0.0014693299,0.49212486,0.40807873,0.0018517865,0.0032737067,0.012137122,0.000040152827,0.00006695975,0.009928951,0.06337702,0.006954344],"study_design_scores_gemma":[0.011562496,0.00019427991,0.4753278,0.42949507,0.0064800265,0.0022973996,0.004916702,0.00018279263,0.00016575865,0.0011037231,0.06779888,0.00047508063],"about_ca_topic_score_codex":0.000024251525,"about_ca_topic_score_gemma":0.000013558737,"teacher_disagreement_score":0.26721582,"about_ca_system_score_codex":0.00015521397,"about_ca_system_score_gemma":0.00011490687,"threshold_uncertainty_score":0.42876455},"labels":[],"label_agreement":null},{"id":"W4413427728","doi":"10.18553/jmcp.2025.24302","title":"Changes in urine albumin-to-creatinine ratio and health care resource utilization and costs in patients with type 2 diabetes and chronic kidney disease","year":2025,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Creatinine; Kidney disease; Diabetes mellitus; Urine; Type 2 diabetes; Albumin; Disease; Intensive care medicine; Albuminuria; Internal medicine; Health care; Urology; Endocrinology","score_opus":0.012184667022061679,"score_gpt":0.304678814540722,"score_spread":0.2924941475186603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413427728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711045,0.023923384,0.0000026194555,0.0038016893,0.0000858898,0.0006721009,0.0000321046,0.000007703044,0.0003700094],"genre_scores_gemma":[0.99383974,0.0020190512,0.00004764449,0.00366588,0.00025436058,0.00000587462,0.00010852906,0.00001767543,0.000041269595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883014,0.00008087664,0.00034261344,0.00022940038,0.00025717917,0.00025979287],"domain_scores_gemma":[0.9988398,0.00005287645,0.00015867133,0.000120782046,0.00019179838,0.0006360749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023111847,0.00017415154,0.00039992182,0.0005353618,0.000068287474,0.00003806785,0.000055856206,0.000025559455,0.000029780069],"category_scores_gemma":[0.00020718585,0.00014697415,0.000022379554,0.00043959,0.000057075667,0.00010186514,0.00007380729,0.00021609405,3.420784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014026525,0.00011435297,0.9045545,0.0012650552,0.000053256215,0.00004205119,0.0012853955,0.0000058391324,0.000035420642,0.000018061655,0.002925723,0.08829773],"study_design_scores_gemma":[0.013043914,0.00072897266,0.9605997,0.0021438408,0.00019017697,0.0000010107051,0.0010976861,0.000051792264,0.00033186426,0.0000048694187,0.02166985,0.0001362873],"about_ca_topic_score_codex":0.00003070714,"about_ca_topic_score_gemma":0.0005965039,"teacher_disagreement_score":0.088161446,"about_ca_system_score_codex":0.00057359715,"about_ca_system_score_gemma":0.0006942355,"threshold_uncertainty_score":0.5993432},"labels":[],"label_agreement":null}]}